{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:37:13Z","timestamp":1791333433465,"version":"4.3.1"},"reference-count":510,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T00:00:00Z","timestamp":1512691200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00702-017-1821-9","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T10:39:46Z","timestamp":1512729586000},"page":"615-650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":243,"title":["Dementia with Lewy bodies and Parkinson\u2019s disease-dementia: current concepts and controversies"],"prefix":"10.1007","volume":"125","author":[{"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"1821_CR1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jns.2009.08.034","volume":"289","author":"D Aarsland","year":"2010","unstructured":"Aarsland D, Kurz MW (2010a) The epidemiology of dementia associated with Parkinson disease. J Neurol Sci 289:18\u201322","journal-title":"J Neurol Sci"},{"key":"1821_CR2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1750-3639.2009.00369.x","volume":"20","author":"D Aarsland","year":"2010","unstructured":"Aarsland D, Kurz MW (2010b) The epidemiology of dementia associated with Parkinson\u2019s disease. Brain Pathol 20:633\u2013639","journal-title":"Brain Pathol"},{"key":"1821_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/0891988704267470","volume":"17","author":"D Aarsland","year":"2004","unstructured":"Aarsland D, Ballard CG, Halliday G (2004) Are Parkinson\u2019s disease with dementia and dementia with Lewy bodies the same entity? J Geriatr Psychiatry Neurol 17:137\u2013145","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"1821_CR4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4088\/JCP.v66n0514","volume":"66","author":"D Aarsland","year":"2005","unstructured":"Aarsland D, Perry R, Larsen JP, McKeith IG, O\u2019Brien JT, Perry EK, Burn D, Ballard CG (2005) Neuroleptic sensitivity in Parkinson\u2019s disease and parkinsonian dementias. J Clin Psychiatry 66:633\u2013637","journal-title":"J Clin Psychiatry"},{"key":"1821_CR5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1474-4422(09)70146-2","volume":"8","author":"D Aarsland","year":"2009","unstructured":"Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K, Leroi I, Pozo-Rodriguez F, Minthon L, Londos E (2009a) Memantine in patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol 8:613\u2013618","journal-title":"Lancet Neurol"},{"key":"1821_CR6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1017\/S1041610208008612","volume":"21","author":"D Aarsland","year":"2009","unstructured":"Aarsland D, Londos E, Ballard C (2009b) Parkinson\u2019s disease dementia and dementia with Lewy bodies: different aspects of one entity. Int Psychogeriatr 21:216\u2013219","journal-title":"Int Psychogeriatr"},{"key":"1821_CR7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C (2017) Cognitive decline in Parkinson disease. Nat Rev Neurol 13:217\u2013231","journal-title":"Nat Rev Neurol"},{"key":"1821_CR8","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/mds.26668","volume":"31","author":"C Abdelnour","year":"2016","unstructured":"Abdelnour C, van Steenoven I, Londos E, Blanc F, Auestad B, Kramberger MG, Zetterberg H, Mollenhauer B, Boada M, Aarsland D (2016) Alzheimer\u2019s disease cerebrospinal fluid biomarkers predict cognitive decline in Lewy body dementia. Mov Disord 31:1203\u20131208","journal-title":"Mov Disord"},{"key":"1821_CR9","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1523\/JNEUROSCI.3047-16.2016","volume":"37","author":"DH Adamowicz","year":"2017","unstructured":"Adamowicz DH, Roy S, Salmon DP, Galasko DR, Hansen LA, Masliah E, Gage FH (2017) Hippocampal alpha-synuclein in dementia with Lewy bodies contributes to memory impairment and is consistent with spread of pathology. J Neurosci 37:1675\u20131684","journal-title":"J Neurosci"},{"key":"1821_CR10","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/ene.13395","volume":"24","author":"CH Adler","year":"2017","unstructured":"Adler CH, Beach TG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MN, Patel A, Sue LI, Serrano G, Jacobson SA, Davis K, Belden CM, Dugger BN, Paciga SA, Winslow AR, Hirst WD, Hentz JG (2017) GBA mutations in Parkinson disease: earlier death but similar neuropathological features. Eur J Neurol 24:1363\u20131368","journal-title":"Eur J Neurol"},{"key":"1821_CR11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mdc3.12290","volume":"3","author":"RS Akhtar","year":"2016","unstructured":"Akhtar RS, Xie SX, Brennan L, Pontecorvo MJ, Hurtig HI, Trojanowski JQ, Weintraub D, Siderowf AD (2016) Amyloid-beta positron emission tomography imaging of Alzheimer\u2019s pathology in Parkinson\u2019s disease dementia. Mov Disord Clin Pract 3:367\u2013375","journal-title":"Mov Disord Clin Pract"},{"key":"1821_CR12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00401-009-0523-2","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Parchi P, Parkkinen L, Patsouris E, Roggendorf W, Rozemuller A, Stadelmann-Nessler C, Streichenberger N, Thal DR, Kretzschmar H (2009) Staging\/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:635\u2013652","journal-title":"Acta Neuropathol"},{"key":"1821_CR13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.nbd.2005.05.001","volume":"20","author":"JL Albasanz","year":"2005","unstructured":"Albasanz JL, Dalfo E, Ferrer I, Martin M (2005) Impaired metabotropic glutamate receptor\/phospholipase C signaling pathway in the cerebral cortex in Alzheimer\u2019s disease and dementia with Lewy bodies correlates with stage of Alzheimer\u2019s-disease-related changes. Neurobiol Dis 20:685\u2013693","journal-title":"Neurobiol Dis"},{"key":"1821_CR14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40478-015-0249-4","volume":"3","author":"A Alexandris","year":"2015","unstructured":"Alexandris A, Liu AK, Chang RC, Pearce RK, Gentleman SM (2015) Differential expression of galanin in the cholinergic basal forebrain of patients with Lewy body disorders. Acta Neuropathol Commun 3:77","journal-title":"Acta Neuropathol Commun"},{"key":"1821_CR15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-160946","volume":"57","author":"A Alghamdi","year":"2017","unstructured":"Alghamdi A, Vallortigara J, Howlett DR, Broadstock M, Hortobagyi T, Ballard C, Thomas AJ, O\u2019Brien JT, Aarsland D, Attems J, Francis PT, Whitfield DR (2017) Reduction of RPT6\/S8 (a proteasome component) and proteasome activity in the cortex is associated with cognitive impairment in Lewy body dementia. J Alzheimers Dis 57:373\u2013386","journal-title":"J Alzheimers Dis"},{"key":"1821_CR16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000070676","volume":"16","author":"OP Almeida","year":"2003","unstructured":"Almeida OP, Burton EJ, McKeith I, Gholkar A, Burn D, O\u2019Brien JT (2003) MRI study of caudate nucleus volume in Parkinson\u2019s disease with and without dementia with Lewy bodies and Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 16:57\u201363","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1821_CR17","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders 5th Ed. (DSM\u20135)","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders 5th Ed. (DSM\u20135). American Psychiatric Publishing, Arlington"},{"key":"1821_CR18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/gps.2496","volume":"26","author":"M Andersson","year":"2011","unstructured":"Andersson M, Zetterberg H, Minthon L, Blennow K, Londos E (2011) The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson\u2019s disease dementia. Int J Geriatr Psychiatry 26:100\u2013105","journal-title":"Int J Geriatr Psychiatry"},{"key":"1821_CR19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-014-1358-z","volume":"129","author":"N Aoki","year":"2015","unstructured":"Aoki N, Murray ME, Ogaki K, Fujioka S, Rutherford NJ, Rademakers R, Ross OA, Dickson DW (2015) Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A. Acta Neuropathol 129:53\u201364","journal-title":"Acta Neuropathol"},{"key":"1821_CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00401-008-0480-1","volume":"117","author":"T Arai","year":"2009","unstructured":"Arai T, Mackenzie IR, Hasegawa M, Nonoka T, Niizato K, Tsuchiya K, Iritani S, Onaya M, Akiyama H (2009) Phosphorylated TDP-43 in Alzheimer\u2019s disease and dementia with Lewy bodies. Acta Neuropathol 117:125\u2013136","journal-title":"Acta Neuropathol"},{"key":"1821_CR21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bandl.2011.09.004","volume":"120","author":"S Ash","year":"2012","unstructured":"Ash S, McMillan C, Gross RG, Cook P, Gunawardena D, Morgan B, Boller A, Siderowf A, Grossman M (2012) Impairments of speech fluency in Lewy body spectrum disorder. Brain Lang 120:290\u2013302","journal-title":"Brain Lang"},{"key":"1821_CR22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1474-4422(16)30282-4","volume":"16","author":"J Attems","year":"2017","unstructured":"Attems J (2017) Alzheimer\u2019s disease pathology in synucleinopathies. Lancet Neurol 16:22\u201323","journal-title":"Lancet Neurol"},{"key":"1821_CR23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neurobiolaging.2017.03.030","volume":"55","author":"C Babiloni","year":"2017","unstructured":"Babiloni C, Del Percio C, Lizio R, Noce G, Cordone S, Lopez S, Soricelli A, Ferri R, Pascarelli MT, Nobili F, Arnaldi D, Aarsland D, Orzi F, Buttinelli C, Giubilei F, Onofrj M, Stocchi F, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Caravias G, Garn H, Sorpresi F, Pievani M, Frisoni GB, D\u2019Antonio F, De Lena C, Guntekin B, Hanoglu L, Basar E, Yener G, Emek-Savas DD, Triggiani AI, Franciotti R, De Pandis MF, Bonanni L (2017) Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer\u2019s and Lewy body diseases: an EEG study. Neurobiol Aging 55:143\u2013158","journal-title":"Neurobiol Aging"},{"key":"1821_CR24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jns.2017.08.3259","volume":"381","author":"D Backstrom","year":"2017","unstructured":"Backstrom D, Domellof ME, Granasen G, Linder J, Mayans S, Elgh E, Mo SJ, Forsgren L (2017a) PITX3 genotype and risk of dementia in Parkinson\u2019s disease: a population-based study. J Neurol Sci 381:278\u2013284","journal-title":"J Neurol Sci"},{"key":"1821_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12812","author":"D Backstrom","year":"2017","unstructured":"Backstrom D, Eriksson Domellof M, Granasen G, Linder J, Mayans S, Elgh E, Zetterberg H, Blennow K, Forsgren L (2017b) Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson\u2019s disease. Acta Neurol Scand. https:\/\/doi.org\/10.1111\/ane.12812","journal-title":"Acta Neurol Scand"},{"key":"1821_CR26","doi-asserted-by":"crossref","first-page":"e26609","DOI":"10.1371\/journal.pone.0026609","volume":"6","author":"N Badiola","year":"2011","unstructured":"Badiola N, de Oliveira RM, Herrera F, Guardia-Laguarta C, Goncalves SA, Pera M, Suarez-Calvet M, Clarimon J, Outeiro TF, Lleo A (2011) Tau enhances alpha-synuclein aggregation and toxicity in cellular models of synucleinopathy. PLoS One 6:e26609","journal-title":"PLoS One"},{"key":"1821_CR27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hbm.22622","volume":"36","author":"HC Baggio","year":"2015","unstructured":"Baggio HC, Segura B, Sala-Llonch R, Marti MJ, Valldeoriola F, Compta Y, Tolosa E, Junque C (2015) Cognitive impairment and resting-state network connectivity in Parkinson\u2019s disease. Hum Brain Mapp 36:199\u2013212","journal-title":"Hum Brain Mapp"},{"key":"1821_CR28","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","volume":"67","author":"C Ballard","year":"2006","unstructured":"Ballard C, Ziabreva I, Perry R, Larsen JP, O\u2019Brien J, McKeith I, Perry E, Aarsland D (2006) Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 67:1931\u20131934","journal-title":"Neurology"},{"key":"1821_CR29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/jnnp.72.3.406","volume":"72","author":"R Barber","year":"2002","unstructured":"Barber R, McKeith I, Ballard C, O\u2019Brien J (2002) Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer\u2019s disease, and vascular dementia. J Neurol Neurosurg Psychiatry 72:406\u2013407","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/nan.12303","volume":"42","author":"RA Barker","year":"2016","unstructured":"Barker RA, Williams-Gray CH (2016) Review: the spectrum of clinical features seen with alpha synuclein pathology. Neuropathol Appl Neurobiol 42:6\u201319","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1821_CR31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.brainres.2015.06.002","volume":"1628","author":"PJ Barrett","year":"2015","unstructured":"Barrett PJ, Timothy Greenamyre J (2015) Post-translational modification of alpha-synuclein in Parkinson\u2019s disease. Brain Res 1628:247\u2013253","journal-title":"Brain Res"},{"key":"1821_CR32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1326-5-55","volume":"5","author":"C Bate","year":"2010","unstructured":"Bate C, Gentleman S, Williams A (2010) alpha-synuclein induced synapse damage is enhanced by amyloid-beta1-42. Mol Neurodegener 5:55","journal-title":"Mol Neurodegener"},{"key":"1821_CR33","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170609080000","author":"M Bauckneht","year":"2017","unstructured":"Bauckneht M, Arnaldi D, Nobili F, Aarsland D, Morbelli S (2017) New tracers and new perspectives for molecular imaging in Lewy body diseases. Curr Med Chem. https:\/\/doi.org\/10.2174\/0929867324666170609080000","journal-title":"Curr Med Chem"},{"key":"1821_CR34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG, Arizona Parkinson\u2019s Disease Consortium (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613\u2013634","journal-title":"Acta Neuropathol"},{"key":"1821_CR35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/nan.12297","volume":"42","author":"A Bellucci","year":"2016","unstructured":"Bellucci A, Mercuri NB, Venneri A, Faustini G, Longhena F, Pizzi M, Missale C, Spano P (2016) Review: Parkinson\u2019s disease: from synaptic loss to connectome dysfunction. Neuropathol Appl Neurobiol 42:77\u201394","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1821_CR36","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jalz.2016.04.005","volume":"12","author":"E Bereczki","year":"2016","unstructured":"Bereczki E, Francis PT, Howlett D, Pereira JB, Hoglund K, Bogstedt A, Cedazo-Minguez A, Baek JH, Hortobagyi T, Attems J, Ballard C, Aarsland D (2016) Synaptic proteins predict cognitive decline in Alzheimer\u2019s disease and Lewy body dementia. Alzheimers Dement 12:1149\u20131158","journal-title":"Alzheimers Dement"},{"key":"1821_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41531-41017-40008-41532","volume":"3","author":"E Bereczki","year":"2017","unstructured":"Bereczki E, Bogstedt A, H\u00f6glund K, Tsitsi P, Brodin L, Ballard C, Svenningsson P, Aarsland D (2017a) Synaptic proteins in CSF relate to Parkinson\u2019s disease stage markers. Parkinson\u2019s Dis 3:7. https:\/\/doi.org\/10.1038\/s41531-41017-40008-41532","journal-title":"Parkinson\u2019s Dis"},{"key":"1821_CR38","doi-asserted-by":"crossref","unstructured":"Bereczki E, Branca RM, Francisc PT, Pereira JB, Baek J-H, Hortob\u00e1gyi T, Winblad B, Ballard C, Lehti\u00f6 J, Aarsland D (2017) Synaptic markers of cognitive decline in neurodegenerative diseases : a proteomic approach. Brain (accepted)","DOI":"10.1093\/brain\/awx352"},{"key":"1821_CR39","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/mds.25844","volume":"29","author":"D Berg","year":"2014","unstructured":"Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2014) Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson\u2019s disease. Mov Disord 29:454\u2013462","journal-title":"Mov Disord"},{"key":"1821_CR40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/mds.26481","volume":"31","author":"AL Bergstrom","year":"2016","unstructured":"Bergstrom AL, Kallunki P, Fog K (2016) Development of passive immunotherapies for synucleinopathies. Mov Disord 31:203\u2013213","journal-title":"Mov Disord"},{"key":"1821_CR41","doi-asserted-by":"crossref","first-page":"e0147319","DOI":"10.1371\/journal.pone.0147319","volume":"11","author":"Y Berlyand","year":"2016","unstructured":"Berlyand Y, Weintraub D, Xie SX, Mellis IA, Doshi J, Rick J, McBride J, Davatzikos C, Shaw LM, Hurtig H, Trojanowski JQ, Chen-Plotkin AS (2016) An Alzheimer\u2019s disease-derived biomarker signature identifies Parkinson\u2019s disease patients with dementia. PLoS One 11:e0147319","journal-title":"PLoS One"},{"key":"1821_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1789.2010.01117.x","volume":"31","author":"HG Bernstein","year":"2011","unstructured":"Bernstein HG, Johnson M, Perry RH, LeBeau FE, Dobrowolny H, Bogerts B, Perry EK (2011) Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies. Neuropathology 31:1\u201310","journal-title":"Neuropathology"},{"key":"1821_CR43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1212\/01.wnl.0000269666.62598.1c","volume":"69","author":"MK Beyer","year":"2007","unstructured":"Beyer MK, Larsen JP, Aarsland D (2007) Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 69:747\u2013754","journal-title":"Neurology"},{"key":"1821_CR44","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/761571","author":"M Bibl","year":"2010","unstructured":"Bibl M, Esselmann H, Lewczuk P, Trenkwalder C, Otto M, Kornhuber J, Wiltfang J, Mollenhauer B (2010) Combined analysis of CSF tau, Abeta 42, Abeta 1-42 and Abeta 1-40 in Alzheimer\u2019s disease, dementia with Lewy bodies and Parkinson\u2019s disease dementia. Int J Alzheimers Dis. https:\/\/doi.org\/10.4061\/2010\/761571","journal-title":"Int J Alzheimers Dis"},{"key":"1821_CR45","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/npjparkd.2016.18","volume":"2","author":"R Biundo","year":"2016","unstructured":"Biundo R, Weis L, Antonini A (2016) Cognitive decline in Parkinson\u2019s disease: the complex picture. NPJ Parkinsons Dis 2:16018","journal-title":"NPJ Parkinsons Dis"},{"key":"1821_CR46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13195-017-0272-8","volume":"9","author":"F Blanc","year":"2017","unstructured":"Blanc F, Mahmoudi R, Jonveaux T, Galmiche J, Chopard G, Cretin B, Demuynck C, Martin-Hunyadi C, Philippi N, Sellal F, Michel JM, Tio G, Stackfleth M, Vandel P, Magnin E, Novella JL, Kaltenbach G, Benetos A, Sauleau EA (2017) Long-term cognitive outcome of Alzheimer\u2019s disease and dementia with Lewy bodies: dual disease is worse. Alzheimers Res Ther 9:47","journal-title":"Alzheimers Res Ther"},{"key":"1821_CR47","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(13)70054-1","volume":"12","author":"BF Boeve","year":"2013","unstructured":"Boeve BF (2013) Idiopathic REM sleep behaviour disorder in the development of Parkinson\u2019s disease. Lancet Neurol 12:469\u2013482","journal-title":"Lancet Neurol"},{"key":"1821_CR48","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/mds.26721","volume":"31","author":"BF Boeve","year":"2016","unstructured":"Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, Singleton AB, Taylor A, Tsuang D, Weintraub D, Zabetian CP (2016) Arguing against the proposed definition changes of PD. Mov Disord 31:1619\u20131622","journal-title":"Mov Disord"},{"key":"1821_CR49","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2967\/jnumed.111.089946","volume":"52","author":"NI Bohnen","year":"2011","unstructured":"Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA, Kuhl DE (2011) Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. J Nucl Med 52:848\u2013855","journal-title":"J Nucl Med"},{"key":"1821_CR50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11910-017-0789-z","volume":"17","author":"NI Bohnen","year":"2017","unstructured":"Bohnen NI, Muller M, Frey KA (2017) Molecular imaging and updated diagnostic criteria in Lewy body dementias. Curr Neurol Neurosci Rep 17:73","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1821_CR51","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/brain\/awm322","volume":"131","author":"L Bonanni","year":"2008","unstructured":"Bonanni L, Thomas A, Tiraboschi P, Perfetti B, Varanese S, Onofrj M (2008) EEG comparisons in early Alzheimer\u2019s disease, dementia with Lewy bodies and Parkinson\u2019s disease with dementia patients with a 2-year follow-up. Brain 131:690\u2013705","journal-title":"Brain"},{"key":"1821_CR52","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3233\/JAD-160435","volume":"54","author":"L Bonanni","year":"2016","unstructured":"Bonanni L, Franciotti R, Nobili F, Kramberger MG, Taylor JP, Garcia-Ptacek S, Falasca NW, Fama F, Cromarty R, Onofrj M, Aarsland D (2016) EEG markers of dementia with Lewy bodies: a multicenter cohort study. J Alzheimers Dis 54:1649\u20131657","journal-title":"J Alzheimers Dis"},{"key":"1821_CR53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13195-015-0128-z","volume":"7","author":"BP Boot","year":"2015","unstructured":"Boot BP (2015) Comprehensive treatment of dementia with Lewy bodies. Alzheimers Res Ther 7:45","journal-title":"Alzheimers Res Ther"},{"key":"1821_CR54","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.parkreldis.2015.06.013","volume":"21","author":"B Borroni","year":"2015","unstructured":"Borroni B, Premi E, Formenti A, Turrone R, Alberici A, Cottini E, Rizzetti C, Gasparotti R, Padovani A (2015) Structural and functional imaging study in dementia with Lewy bodies and Parkinson\u2019s disease dementia. Parkinsonism Relat Disord 21:1049\u20131055","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR55","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","volume":"70","author":"H Braak","year":"2008","unstructured":"Braak H, Del Tredici K (2008) Nervous system pathology in sporadic Parkinson disease. Neurology 70:1916\u20131925","journal-title":"Neurology"},{"key":"1821_CR56","first-page":"S73","volume":"7","author":"H Braak","year":"2017","unstructured":"Braak H, Del Tredici K (2017) Neuropathological staging of brain pathology in sporadic Parkinson\u2019s disease: separating the wheat from the chaff. J Parkinsons Dis 7:S73\u2013S87","journal-title":"J Parkinsons Dis"},{"key":"1821_CR57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"1821_CR58","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","volume":"64","author":"H Braak","year":"2005","unstructured":"Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:1404\u20131410","journal-title":"Neurology"},{"key":"1821_CR59","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/mds.21065","volume":"21","author":"H Braak","year":"2006","unstructured":"Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K (2006) Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson\u2019s disease reconsidered. Mov Disord 21:2042\u20132051","journal-title":"Mov Disord"},{"key":"1821_CR60","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","volume":"23","author":"J Bras","year":"2014","unstructured":"Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS, Marder K, Van Der Flier WM, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns N, Halliday GM, Mann D, Pickering-Brown S, Dickson DW, Singleton A, Hardy J (2014) Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum Mol Genet 23:6139\u20136146","journal-title":"Hum Mol Genet"},{"key":"1821_CR61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jns.2015.11.004","volume":"359","author":"F Brigo","year":"2015","unstructured":"Brigo F, Turri G, Tinazzi M (2015) 123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias. J Neurol Sci 359:161\u2013171","journal-title":"J Neurol Sci"},{"key":"1821_CR62","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3233\/JAD-160294","volume":"53","author":"K Bronnick","year":"2016","unstructured":"Bronnick K, Breitve MH, Rongve A, Aarsland D (2016) Neurocognitive deficits distinguishing mild dementia with Lewy bodies from mild Alzheimer\u2019s disease are associated with parkinsonism. J Alzheimers Dis 53:1277\u20131285","journal-title":"J Alzheimers Dis"},{"issue":"(Suppl. 2)","key":"1821_CR63","doi-asserted-by":"crossref","first-page":"S742","DOI":"10.1002\/mds.22581","volume":"24","author":"DJ Brooks","year":"2009","unstructured":"Brooks DJ (2009) Imaging amyloid in Parkinson\u2019s disease dementia and dementia with Lewy bodies with positron emission tomography. Mov Disord 24((Suppl. 2)):S742\u2013S747","journal-title":"Mov Disord"},{"key":"1821_CR64","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.1474","author":"EG Brown","year":"2017","unstructured":"Brown EG, Tanner CM (2017) Impaired cognition and the risk of Parkinson disease: trouble in mind. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2017.1474","journal-title":"JAMA Neurol"},{"key":"1821_CR65","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1523\/JNEUROSCI.1788-16.2017","volume":"37","author":"P Brundin","year":"2017","unstructured":"Brundin P, Melki R (2017) Prying into the prion hypothesis for Parkinson\u2019s disease. J Neurosci 37:9808\u20139818","journal-title":"J Neurosci"},{"key":"1821_CR66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.expneurol.2017.10.003","volume":"298","author":"P Brundin","year":"2017","unstructured":"Brundin P, Dave KD, Kordower JH (2017) Therapeutic approaches to target alpha-synuclein pathology. Exp Neurol 298:225\u2013235","journal-title":"Exp Neurol"},{"key":"1821_CR67","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3233\/JAD-160698","volume":"55","author":"M Buongiorno","year":"2017","unstructured":"Buongiorno M, Antonelli F, Compta Y, Fernandez Y, Pavia J, Lomena F, Rios J, Ramirez I, Garcia JR, Soler M, Camara A, Fernandez M, Basora M, Salazar F, Sanchez-Etayo G, Valldeoriola F, Barrio JR, Marti MJ (2017) Cross-sectional and longitudinal cognitive correlates of FDDNP PET and CSF amyloid-beta and tau in Parkinson\u2019s disease. J Alzheimers Dis 55:1261\u20131272","journal-title":"J Alzheimers Dis"},{"key":"1821_CR68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2217\/fnl-2017-0009","volume":"12","author":"JT Burchell","year":"2017","unstructured":"Burchell JT, Panegyres PK (2017) New cerebrospinal fluid biomarkers in Alzheimer\u2019s disease. Future Neurol 12:53\u201356","journal-title":"Future Neurol"},{"key":"1821_CR69","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/01.wco.0000247607.34697.a2","volume":"19","author":"DJ Burn","year":"2006","unstructured":"Burn DJ (2006) Cortical Lewy body disease and Parkinson\u2019s disease dementia. Curr Opin Neurol 19:572\u2013579","journal-title":"Curr Opin Neurol"},{"key":"1821_CR70","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/mds.20652","volume":"20","author":"EJ Burton","year":"2005","unstructured":"Burton EJ, McKeith IG, Burn DJ, O\u2019Brien JT (2005) Brain atrophy rates in Parkinson\u2019s disease with and without dementia using serial magnetic resonance imaging. Mov Disord 20:1571\u20131576","journal-title":"Mov Disord"},{"key":"1821_CR71","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/01.JGP.0000236596.56982.1c","volume":"14","author":"EJ Burton","year":"2006","unstructured":"Burton EJ, McKeith IG, Burn DJ, Firbank MJ, O\u2019Brien JT (2006) Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging. Am J Geriatr Psychiatry 14:842\u2013849","journal-title":"Am J Geriatr Psychiatry"},{"key":"1821_CR72","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/brain\/awn298","volume":"132","author":"EJ Burton","year":"2009","unstructured":"Burton EJ, Barber R, Mukaetova-Ladinska EB, Robson J, Perry RH, Jaros E, Kalaria RN, O\u2019Brien JT (2009) Medial temporal lobe atrophy on MRI differentiates Alzheimer\u2019s disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain 132:195\u2013203","journal-title":"Brain"},{"key":"1821_CR73","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jnnp-2012-304095","volume":"84","author":"A Cagnin","year":"2013","unstructured":"Cagnin A, Gnoato F, Jelcic N, Favaretto S, Zarantonello G, Ermani M, Dam M (2013) Clinical and cognitive correlates of visual hallucinations in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 84:505\u2013510","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR74","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mds.10444","volume":"18","author":"R Camicioli","year":"2003","unstructured":"Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA (2003) Parkinson\u2019s disease is associated with hippocampal atrophy. Mov Disord 18:784\u2013790","journal-title":"Mov Disord"},{"key":"1821_CR002","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-00017-02733-00446","author":"MG Cersosimo","year":"2017","unstructured":"Cersosimo MG (2017) Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies. Cell Tissue Res. https:\/\/doi.org\/10.1007\/s00441-00017-02733-00446","journal-title":"Cell Tissue Res"},{"key":"1821_CR75","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajmg.b.32390","volume":"171B","author":"L Cervera-Carles","year":"2016","unstructured":"Cervera-Carles L, Pagonabarraga J, Pascual-Sedano B, Pastor P, Campolongo A, Fortea J, Blesa R, Alcolea D, Morenas-Rodriguez E, Sala I, Lleo A, Kulisevsky J, Clarimon J (2016) Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases. Am J Med Genet B Neuropsychiatr Genet 171B:175\u2013180","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"Suppl 1","key":"1821_CR76","first-page":"1","volume":"20","author":"RS Chaves","year":"2010","unstructured":"Chaves RS, Melo TQ, D\u2019Unhao AM, Martins SA, Ferrari MFR (2010) Alpha synuclein, beta amyloid and hyperphosphorylated tau aggregation after mitochondrial complex I impairment (abs). Brain Pathol 20(Suppl 1):1","journal-title":"Brain Pathol"},{"key":"1821_CR77","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.ejrad.2015.04.014","volume":"84","author":"B Chen","year":"2015","unstructured":"Chen B, Fan GG, Liu H, Wang S (2015) Changes in anatomical and functional connectivity of Parkinson\u2019s disease patients according to cognitive status. Eur J Radiol 84:1318\u20131324","journal-title":"Eur J Radiol"},{"key":"1821_CR78","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13195-017-0276-4","volume":"9","author":"D Chiasserini","year":"2017","unstructured":"Chiasserini D, Biscetti L, Eusebi P, Salvadori N, Frattini G, Simoni S, De Roeck N, Tambasco N, Stoops E, Vanderstichele H, Engelborghs S, Mollenhauer B, Calabresi P, Parnetti L (2017) Differential role of CSF fatty acid binding protein 3, alpha-synuclein, and Alzheimer\u2019s disease core biomarkers in Lewy body disorders and Alzheimer\u2019s dementia. Alzheimers Res Ther 9:52","journal-title":"Alzheimers Res Ther"},{"key":"1821_CR79","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000339363","volume":"33","author":"Y Chiba","year":"2012","unstructured":"Chiba Y, Fujishiro H, Iseki E, Ota K, Kasanuki K, Hirayasu Y, Satoa K (2012) Retrospective survey of prodromal symptoms in dementia with Lewy bodies: comparison with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 33:273\u2013281","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1821_CR80","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/pcn.12101","volume":"68","author":"Y Chiba","year":"2014","unstructured":"Chiba Y, Iseki E, Fujishiro H, Ota K, Kasanuki K, Arai H, Hirayasu Y, Sato K (2014) Primary visual cortical metabolism and rapid eye movement sleep behavior disorder in dementia with Lewy bodies. Psychiatry Clin Neurosci 68:137\u2013144","journal-title":"Psychiatry Clin Neurosci"},{"key":"1821_CR81","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/gps.4144","volume":"30","author":"Y Chiba","year":"2015","unstructured":"Chiba Y, Fujishiro H, Ota K, Kasanuki K, Arai H, Hirayasu Y, Sato K, Iseki E (2015) Clinical profiles of dementia with Lewy bodies with and without Alzheimer\u2019s disease-like hypometabolism. Int J Geriatr Psychiatry 30:316\u2013323","journal-title":"Int J Geriatr Psychiatry"},{"key":"1821_CR82","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jns.2017.09.010","volume":"381","author":"MH Choi","year":"2017","unstructured":"Choi MH, Yoon JH, Yong SW (2017) Cardiac sympathetic denervation and dementia in de novo Parkinson\u2019s disease: a 7-year follow-up study. J Neurol Sci 381:291\u2013295","journal-title":"J Neurol Sci"},{"key":"1821_CR83","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.24777","volume":"80","author":"R Cilia","year":"2016","unstructured":"Cilia R, Tunesi S, Marotta G, Cereda E, Siri C, Tesei S, Zecchinelli AL, Canesi M, Mariani CB, Meucci N, Sacilotto G, Zini M, Barichella M, Magnani C, Duga S, Asselta R, Solda G, Seresini A, Seia M, Pezzoli G, Goldwurm S (2016) Survival and dementia in GBA-associated Parkinson\u2019s disease: the mutation matters. Ann Neurol 80:662\u2013673","journal-title":"Ann Neurol"},{"key":"1821_CR84","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archneurol.2009.54","volume":"66","author":"LN Clark","year":"2009","unstructured":"Clark LN, Kartsaklis LA, Wolf Gilbert R, Dorado B, Ross BM, Kisselev S, Verbitsky M, Mejia-Santana H, Cote LJ, Andrews H, Vonsattel JP, Fahn S, Mayeux R, Honig LS, Marder K (2009) Association of glucocerebrosidase mutations with dementia with Lewy bodies. Arch Neurol 66:578\u2013583","journal-title":"Arch Neurol"},{"key":"1821_CR85","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1138718","volume":"318","author":"J Collinge","year":"2007","unstructured":"Collinge J, Clarke AR (2007) A general model of prion strains and their pathogenicity. Science 318:930\u2013936","journal-title":"Science"},{"key":"1821_CR86","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fpsyt.2016.00089","volume":"7","author":"LM Collins","year":"2016","unstructured":"Collins LM, Williams-Gray CH (2016) The genetic basis of cognitive impairment and dementia in Parkinson\u2019s disease. Front Psychiatry 7:89","journal-title":"Front Psychiatry"},{"key":"1821_CR87","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1093\/brain\/aws211","volume":"135","author":"SJ Colloby","year":"2012","unstructured":"Colloby SJ, McParland S, O\u2019Brien JT, Attems J (2012) Neuropathological correlates of dopaminergic imaging in Alzheimer\u2019s disease and Lewy body dementias. Brain 135:2798\u20132808","journal-title":"Brain"},{"key":"1821_CR88","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/WNL.0000000000002839","volume":"87","author":"SJ Colloby","year":"2016","unstructured":"Colloby SJ, McKeith IG, Burn DJ, Wyper DJ, O\u2019Brien JT, Taylor JP (2016) Cholinergic and perfusion brain networks in Parkinson disease dementia. Neurology 87:178\u2013185","journal-title":"Neurology"},{"key":"1821_CR89","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/NEN.0000000000000018","volume":"72","author":"M Colom-Cadena","year":"2013","unstructured":"Colom-Cadena M, Gelpi E, Charif S, Belbin O, Blesa R, Marti MJ, Clarimon J, Lleo A (2013a) Confluence of alpha-synuclein, tau, and beta-amyloid pathologies in dementia with Lewy bodies. J Neuropathol Exp Neurol 72:1203\u20131212","journal-title":"J Neuropathol Exp Neurol"},{"key":"1821_CR90","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.neurobiolaging.2012.06.015","volume":"34","author":"M Colom-Cadena","year":"2013","unstructured":"Colom-Cadena M, Gelpi E, Marti MJ, Charif S, Dols-Icardo O, Blesa R, Clarimon J, Lleo A (2013b) MAPT H1 haplotype is associated with enhanced alpha-synuclein deposition in dementia with Lewy bodies. Neurobiol Aging 34:936\u2013942","journal-title":"Neurobiol Aging"},{"key":"1821_CR91","first-page":"216","volume":"76","author":"M Colom-Cadena","year":"2017","unstructured":"Colom-Cadena M, Grau-Rivera O, Planellas L, Cerquera C, Morenas E, Helgueta S, Munoz L, Kulisevsky J, Marti MJ, Tolosa E, Clarimon J, Lleo A, Gelpi E (2017a) Regional overlap of pathologies in Lewy body disorders. J Neuropathol Exp Neurol 76:216\u2013224","journal-title":"J Neuropathol Exp Neurol"},{"key":"1821_CR92","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1093\/brain\/awx275","volume":"140","author":"M Colom-Cadena","year":"2017","unstructured":"Colom-Cadena M, Pegueroles J, Herrmann AG, Henstridge CM, Munoz L, Querol-Vilaseca M, Martin-Paniello CS, Luque-Cabecerans J, Clarimon J, Belbin O, Nunez-Llaves R, Blesa R, Smith C, McKenzie CA, Frosch MP, Roe A, Fortea J, Andilla J, Loza-Alvarez P, Gelpi E, Hyman BT, Spires-Jones TL, Lleo A (2017b) Synaptic phosphorylated alpha-synuclein in dementia with Lewy bodies. Brain 140:3204\u20133214","journal-title":"Brain"},{"key":"1821_CR93","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/jnnp.74.7.852","volume":"74","author":"C Colosimo","year":"2003","unstructured":"Colosimo C, Hughes AJ, Kilford L, Lees AJ (2003) Lewy body cortical involvement may not always predict dementia in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 74:852\u2013856","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR94","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","volume":"134","author":"Y Compta","year":"2011","unstructured":"Compta Y, Parkkinen L, O\u2019Sullivan SS, Vandrovcova J, Holton JL, Collins C, Lashley T, Kallis C, Williams DR, de Silva R, Lees AJ, Revesz T (2011) Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important? Brain 134:1493\u20131505","journal-title":"Brain"},{"key":"1821_CR95","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.parkreldis.2013.03.009","volume":"19","author":"Y Compta","year":"2013","unstructured":"Compta Y, Pereira JB, Rios J, Ibarretxe-Bilbao N, Junque C, Bargallo N, Camara A, Buongiorno M, Fernandez M, Pont-Sunyer C, Marti MJ (2013) Combined dementia-risk biomarkers in Parkinson\u2019s disease: a prospective longitudinal study. Parkinsonism Relat Disord 19:717\u2013724","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR96","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00415-014-7560-z","volume":"262","author":"Y Compta","year":"2015","unstructured":"Compta Y, Valente T, Saura J, Segura B, Iranzo A, Serradell M, Junque C, Tolosa E, Valldeoriola F, Munoz E, Santamaria J, Camara A, Fernandez M, Fortea J, Buongiorno M, Molinuevo JL, Bargallo N, Marti MJ (2015) Correlates of cerebrospinal fluid levels of oligomeric- and total-alpha-synuclein in premotor, motor and dementia stages of Parkinson\u2019s disease. J Neurol 262:294\u2013306","journal-title":"J Neurol"},{"key":"1821_CR97","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jns.2016.06.009","volume":"367","author":"Y Compta","year":"2016","unstructured":"Compta Y, Buongiorno M, Bargallo N, Valldeoriola F, Munoz E, Tolosa E, Rios J, Camara A, Fernandez M, Marti MJ (2016) White matter hyperintensities, cerebrospinal amyloid-beta and dementia in Parkinson\u2019s disease. J Neurol Sci 367:284\u2013290","journal-title":"J Neurol Sci"},{"key":"1821_CR98","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1586\/ern.12.142","volume":"12","author":"BS Connolly","year":"2012","unstructured":"Connolly BS, Fox SH (2012) Drug treatments for the neuropsychiatric complications of Parkinson\u2019s disease. Expert Rev Neurother 12:1439\u20131449","journal-title":"Expert Rev Neurother"},{"key":"1821_CR99","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291717003257","author":"MH Connors","year":"2017","unstructured":"Connors MH, Quinto L, McKeith I, Brodaty H, Allan L, Bamford C, Thomas A, Taylor JP, O'Brien JT (2017) Non-pharmacological interventions for Lewy body dementia: a systematic review. Psychol Med. https:\/\/doi.org\/10.1017\/S0033291717003257","journal-title":"Psychol Med"},{"key":"1821_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.32549","author":"B Creese","year":"2017","unstructured":"Creese B, Bell E, Johar I, Francis P, Ballard C, Aarsland D (2017) Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson\u2019s disease and Lewy body dementias: review and meta-analyses. Am J Med Genet B Neuropsychiatr Genet. https:\/\/doi.org\/10.1002\/ajmg.b.32549","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1821_CR101","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neurobiolaging.2006.10.022","volume":"29","author":"E Dalfo","year":"2008","unstructured":"Dalfo E, Ferrer I (2008) Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases. Neurobiol Aging 29:408\u2013417","journal-title":"Neurobiol Aging"},{"key":"1821_CR102","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1750-3639.2004.tb00082.x","volume":"14","author":"E Dalfo","year":"2004","unstructured":"Dalfo E, Albasanz JL, Martin M, Ferrer I (2004) Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein\/phospholipase C (PLCbeta1) interactions. Brain Pathol 14:388\u2013398","journal-title":"Brain Pathol"},{"key":"1821_CR103","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease. Brain 122:1437\u20131448","journal-title":"Brain"},{"key":"1821_CR104","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.2248","author":"SKL Darweesh","year":"2017","unstructured":"Darweesh SKL, Wolters FJ, Postuma RB, Stricker BH, Hofman A, Koudstaal PJ, Ikram MK, Ikram MA (2017) Association between poor cognitive functioning and risk of incident parkinsonism: the Rotterdam Study. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2017.2248","journal-title":"JAMA Neurol"},{"key":"1821_CR105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13041-017-0316-9","volume":"10","author":"A Datta","year":"2017","unstructured":"Datta A, Chai YL, Tan JM, Lee JH, Francis PT, Chen CP, Sze SK, Lai MKP (2017) An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias. Mol Brain 10:36","journal-title":"Mol Brain"},{"key":"1821_CR106","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jamaneurol.2016.2245","volume":"73","author":"MY Davis","year":"2016","unstructured":"Davis MY, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Goldman JG, Stebbins GT, Bernard B, Wszolek ZK, Ross OA, Dickson DW, Eidelberg D, Mattis PJ, Niethammer M, Yearout D, Hu SC, Cholerton BA, Smith M, Mata IF, Montine TJ, Edwards KL, Zabetian CP (2016) Association of GBA mutations and the E326K polymorphism with motor and cognitive progression in Parkinson disease. JAMA Neurol 73:1217\u20131224","journal-title":"JAMA Neurol"},{"key":"1821_CR107","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.clineuro.2012.11.005","volume":"115","author":"J Reuck De","year":"2013","unstructured":"De Reuck J, Deramecourt V, Cordonnier C, Leys D, Pasquier F, Maurage CA (2013) Prevalence of cerebrovascular lesions in patients with Lewy body dementia: a neuropathological study. Clin Neurol Neurosurg 115:1094\u20131097","journal-title":"Clin Neurol Neurosurg"},{"key":"1821_CR108","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/jnnp-2011-301817","volume":"84","author":"K Tredici Del","year":"2013","unstructured":"Del Tredici K, Braak H (2013) Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson\u2019s disease-related dementia. J Neurol Neurosurg Psychiatry 84:774\u2013783","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR109","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1093\/cercor\/bhu220","volume":"25","author":"S Delli Pizzi","year":"2015","unstructured":"Delli Pizzi S, Franciotti R, Taylor JP, Thomas A, Tartaro A, Onofrj M, Bonanni L (2015) Thalamic involvement in fluctuating cognition in dementia with Lewy bodies: magnetic resonance evidences. Cereb Cortex 25:3682\u20133689","journal-title":"Cereb Cortex"},{"key":"1821_CR110","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.jnen.0000205145.54457.ea","volume":"65","author":"V Deramecourt","year":"2006","unstructured":"Deramecourt V, Bombois S, Maurage CA, Ghestem A, Drobecq H, Vanmechelen E, Lebert F, Pasquier F, Delacourte A (2006) Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol 65:278\u2013288","journal-title":"J Neuropathol Exp Neurol"},{"key":"1821_CR111","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I (2009) Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol 8:1150\u20131157","journal-title":"Lancet Neurol"},{"key":"1821_CR112","first-page":"493","volume":"76","author":"D Dickson","year":"2017","unstructured":"Dickson D, Heckman M, Murray M, Soto-Ortolaza A, Walton R, Diehl N, van Gerpen J, Uitti R, Wszolek Z, Ertekin-Taner N, Knopman D, Petersen R, Graff-Radford N, Boeve B, Bu G, Ferman T, Ross O (2017) Apolipoprotein E4 is associated with Lewy body distribution and pathologic burden independent of Alzheimer\u2019s disease pathology (abstr.). J Neuropathol Exp Neurol 76:493","journal-title":"J Neuropathol Exp Neurol"},{"key":"1821_CR113","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3233\/JAD-121810","volume":"34","author":"JK Dieks","year":"2013","unstructured":"Dieks JK, Gawinecka J, Asif AR, Varges D, Gmitterova K, Streich JH, Dihazi H, Heinemann U, Zerr I (2013) Low-abundant cerebrospinal fluid proteome alterations in dementia with Lewy bodies. J Alzheimers Dis 34:387\u2013397","journal-title":"J Alzheimers Dis"},{"key":"1821_CR114","first-page":"2275","volume":"19","author":"W Ding","year":"2015","unstructured":"Ding W, Ding LJ, Li FF, Han Y, Mu L (2015) Neurodegeneration and cognition in Parkinson\u2019s disease: a review. Eur Rev Med Pharmacol Sci 19:2275\u20132281","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"Suppl 5","key":"1821_CR115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00415-008-5007-0","volume":"255","author":"R Dodel","year":"2008","unstructured":"Dodel R, Csoti I, Ebersbach G, Fuchs G, Hahne M, Kuhn W, Oechsner M, Jost W, Reichmann H, Schulz JB (2008) Lewy body dementia and Parkinson\u2019s disease with dementia. J Neurol 255(Suppl 5):39\u201347","journal-title":"J Neurol"},{"key":"1821_CR117","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1212\/WNL.0000000000004146","volume":"89","author":"V Donadio","year":"2017","unstructured":"Donadio V, Incensi A, Rizzo G, Capellari S, Pantieri R, Stanzani Maserati M, Devigili G, Eleopra R, Defazio G, Montini F, Baruzzi A, Liguori R (2017) A new potential biomarker for dementia with Lewy bodies: Skin nerve alpha-synuclein deposits. Neurology 89:318\u2013326","journal-title":"Neurology"},{"key":"1821_CR118","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/alzrt274","volume":"6","author":"PC Donaghy","year":"2014","unstructured":"Donaghy PC, McKeith IG (2014) The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimers Res Ther 6:46","journal-title":"Alzheimers Res Ther"},{"key":"1821_CR119","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/gps.4742","volume":"32","author":"PC Donaghy","year":"2017","unstructured":"Donaghy PC, Barnett N, Olsen K, Taylor JP, McKeith IG, O\u2019Brien JT, Thomas AJ (2017) Symptoms associated with Lewy body disease in mild cognitive impairment. Int J Geriatr Psychiatry 32:1163\u20131171","journal-title":"Int J Geriatr Psychiatry"},{"key":"1821_CR120","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.21844","volume":"22","author":"B Dubois","year":"2007","unstructured":"Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson\u2019s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314\u20132324","journal-title":"Mov Disord"},{"key":"1821_CR121","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/mds.24003","volume":"27","author":"BN Dugger","year":"2012","unstructured":"Dugger BN, Boeve BF, Murray ME, Parisi JE, Fujishiro H, Dickson DW, Ferman TJ (2012) Rapid eye movement sleep behavior disorder and subtypes in autopsy-confirmed dementia with Lewy bodies. Mov Disord 27:72\u201378","journal-title":"Mov Disord"},{"key":"1821_CR122","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/mds.23391","volume":"25","author":"K Dujardin","year":"2010","unstructured":"Dujardin K, Dubois B, Tison F, Durif F, Bourdeix I, Pere JJ, Duhamel A (2010) Parkinson\u2019s disease dementia can be easily detected in routine clinical practice. Mov Disord 25:2769\u20132776","journal-title":"Mov Disord"},{"issue":"Suppl 5","key":"1821_CR123","first-page":"S9","volume":"17","author":"C Duyckaerts","year":"2002","unstructured":"Duyckaerts C (2002) Is Parkinson\u2019s disease with dementia and dementia with Lewy body the same disease? Answer: no. Mov Disord 17(Suppl 5):S9","journal-title":"Mov Disord"},{"key":"1821_CR124","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","volume":"79","author":"P Edison","year":"2008","unstructured":"Edison P, Rowe CC, Rinne JO, Ng S, Ahmed I, Kemppainen N, Villemagne VL, O\u2019Keefe G, Nagren K, Chaudhury KR, Masters CL, Brooks DJ (2008) Amyloid load in Parkinson\u2019s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry 79:1331\u20131338","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2017.96","volume":"13","author":"FM Elahi","year":"2017","unstructured":"Elahi FM, Miller BL (2017) A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol 13:457\u2013476","journal-title":"Nat Rev Neurol"},{"key":"1821_CR126","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1017\/S1041610215001180","volume":"28","author":"GJ Elder","year":"2016","unstructured":"Elder GJ, Firbank MJ, Kumar H, Chatterjee P, Chakraborty T, Dutt A, Taylor JP (2016) Effects of transcranial direct current stimulation upon attention and visuoperceptual function in Lewy body dementia: a preliminary study. Int Psychogeriatr 28:341\u2013347","journal-title":"Int Psychogeriatr"},{"key":"1821_CR127","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/gps.4719","volume":"32","author":"GJ Elder","year":"2017","unstructured":"Elder GJ, Mactier K, Colloby SJ, Watson R, Blamire AM, O\u2019Brien JT, Taylor JP (2017) The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies. Int J Geriatr Psychiatry 32:1182\u20131189","journal-title":"Int J Geriatr Psychiatry"},{"key":"1821_CR128","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/mds.25518","volume":"28","author":"AE Elia","year":"2013","unstructured":"Elia AE, Petrucci S, Fasano A, Guidi M, Valbonesi S, Bernardini L, Consoli F, Ferraris A, Albanese A, Valente EM (2013) Alpha-synuclein gene duplication: marked intrafamilial variability in two novel pedigrees. Mov Disord 28:813\u2013817","journal-title":"Mov Disord"},{"key":"1821_CR129","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22:1689\u20131707","journal-title":"Mov Disord"},{"key":"1821_CR130","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/mds.26887","volume":"32","author":"D Erskine","year":"2017","unstructured":"Erskine D, Thomas AJ, Attems J, Taylor JP, McKeith IG, Morris CM, Khundakar AA (2017a) Specific patterns of neuronal loss in the pulvinar nucleus in dementia with Lewy bodies. Mov Disord 32:414\u2013422","journal-title":"Mov Disord"},{"key":"1821_CR131","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jagp.2017.01.005","volume":"25","author":"D Erskine","year":"2017","unstructured":"Erskine D, Thomas AJ, Taylor JP, Savage MA, Attems J, McKeith IG, Morris CM, Khundakar AA (2017b) Neuronal loss and alpha-synuclein pathology in the superior colliculus and its relationship to visual hallucinations in dementia with Lewy bodies. Am J Geriatr Psychiatry 25:595\u2013604","journal-title":"Am J Geriatr Psychiatry"},{"key":"1821_CR132","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/mds.27110","volume":"32","author":"P Eusebi","year":"2017","unstructured":"Eusebi P, Giannandrea D, Biscetti L, Abraha I, Chiasserini D, Orso M, Calabresi P, Parnetti L (2017) Diagnostic utility of cerebrospinal fluid alpha-synuclein in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 32:1389\u20131400","journal-title":"Mov Disord"},{"key":"1821_CR133","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1038\/emboj.2012.170","volume":"31","author":"N Exner","year":"2012","unstructured":"Exner N, Lutz AK, Haass C, Winklhofer KF (2012) Mitochondrial dysfunction in Parkinson\u2019s disease: molecular mechanisms and pathophysiological consequences. EMBO J 31:3038\u20133062","journal-title":"EMBO J"},{"key":"1821_CR134","doi-asserted-by":"crossref","first-page":"561-e20","DOI":"10.1111\/ene.13258","volume":"24","author":"ES Fagan","year":"2017","unstructured":"Fagan ES, Pihlstrom L (2017) Genetic risk factors for cognitive decline in Parkinson\u2019s disease: a review of the literature. Eur J Neurol 24:561-e20","journal-title":"Eur J Neurol"},{"key":"1821_CR135","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, Joachim C, Esiri M, Evetts SG, Rolinski M, Baig F, Ruffmann C, Wade-Martins R, Hu MT, Parkkinen L, Green AJ (2016) Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol 3:812\u2013818","journal-title":"Ann Clin Transl Neurol"},{"key":"1821_CR136","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/ene.13028","volume":"23","author":"S Favaretto","year":"2016","unstructured":"Favaretto S, Walter U, Baracchini C, Pompanin S, Busse C, Zorzi G, Ermani M, Cagnin A (2016) Accuracy of transcranial brain parenchyma sonography in the diagnosis of dementia with Lewy bodies. Eur J Neurol 23:1322\u20131328","journal-title":"Eur J Neurol"},{"key":"1821_CR137","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.wnl.0000191325.31068.c4","volume":"66","author":"G F\u00e9nelon","year":"2006","unstructured":"F\u00e9nelon G, Goetz CG, Karenberg A (2006) Hallucinations in Parkinson disease in the prelevodopa era. Neurology 66:93\u201398","journal-title":"Neurology"},{"key":"1821_CR138","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2147\/NDT.S45840","volume":"9","author":"SM Fereshtehnejad","year":"2013","unstructured":"Fereshtehnejad SM, Religa D, Westman E, Aarsland D, Lokk J, Eriksdotter M (2013) Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson\u2019s disease with dementia: data from the Swedish Dementia Quality Registry (SveDem). Neuropsychiatr Dis Treat 9:927\u2013935","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1821_CR139","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1212\/WNL.0b013e31822c9148","volume":"77","author":"TJ Ferman","year":"2011","unstructured":"Ferman TJ, Boeve BF, Smith GE, Lin SC, Silber MH, Pedraza O, Wszolek Z, Graff-Radford NR, Uitti R, Van Gerpen J, Pao W, Knopman D, Pankratz VS, Kantarci K, Boot B, Parisi JE, Dugger BN, Fujishiro H, Petersen RC, Dickson DW (2011) Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology 77:875\u2013882","journal-title":"Neurology"},{"key":"1821_CR140","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/gps.1359","volume":"20","author":"MJ Firbank","year":"2005","unstructured":"Firbank MJ, Burn DJ, McKeith IG, O\u2019Brien JT (2005) Longitudinal study of cerebral blood flow SPECT in Parkinson\u2019s disease with dementia, and dementia with Lewy bodies. Int J Geriatr Psychiatry 20:776\u2013782","journal-title":"Int J Geriatr Psychiatry"},{"key":"1821_CR141","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.23866","author":"MJ Firbank","year":"2017","unstructured":"Firbank MJ, O\u2019Brien JT, Taylor JP (2017) Long reaction times are associated with delayed brain activity in Lewy body dementia. Hum Brain Mapp. https:\/\/doi.org\/10.1002\/hbm.23866","journal-title":"Hum Brain Mapp"},{"key":"1821_CR142","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.26586","volume":"31","author":"A Flores-Cuadrado","year":"2016","unstructured":"Flores-Cuadrado A, Ubeda-Banon I, Saiz-Sanchez D, de la Rosa-Prieto C, Martinez-Marcos A (2016) Hippocampal alpha-synuclein and interneurons in Parkinson\u2019s disease: data from human and mouse models. Mov Disord 31:979\u2013988","journal-title":"Mov Disord"},{"key":"1821_CR143","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.clinph.2013.05.001","volume":"124","author":"LC Fonseca","year":"2013","unstructured":"Fonseca LC, Tedrus GM, Carvas PN, Machado EC (2013) Comparison of quantitative EEG between patients with Alzheimer\u2019s disease and those with Parkinson\u2019s disease dementia. Clin Neurophysiol 124:1970\u20131974","journal-title":"Clin Neurophysiol"},{"key":"1821_CR144","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/mds.23393","volume":"25","author":"ER Foster","year":"2010","unstructured":"Foster ER, Campbell MC, Burack MA, Hartlein J, Flores HP, Cairns NJ, Hershey T, Perlmutter JS (2010) Amyloid imaging of Lewy body-associated disorders. Mov Disord 25:2516\u20132523","journal-title":"Mov Disord"},{"issue":"Suppl 17","key":"1821_CR145","doi-asserted-by":"crossref","first-page":"S351","DOI":"10.1002\/mds.21683","volume":"22","author":"PT Francis","year":"2007","unstructured":"Francis PT, Perry EK (2007) Cholinergic and other neurotransmitter mechanisms in Parkinson\u2019s disease, Parkinson\u2019s disease dementia, and dementia with Lewy bodies. Mov Disord 22(Suppl 17):S351\u2013S357","journal-title":"Mov Disord"},{"key":"1821_CR146","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jns.2017.01.014","volume":"374","author":"K Frei","year":"2017","unstructured":"Frei K, Truong DD (2017) Hallucinations and the spectrum of psychosis in Parkinson\u2019s disease. J Neurol Sci 374:56\u201362","journal-title":"J Neurol Sci"},{"issue":"Suppl 1","key":"1821_CR147","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.parkreldis.2017.07.013","volume":"46","author":"JH Friedman","year":"2018","unstructured":"Friedman JH (2018) Dementia with Lewy bodies and Parkinson disease dementia: become the same disease. Parkinsonism Relat Disord 46(Suppl 1):S6\u2013S9","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR148","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neurobiolaging.2009.05.019","volume":"32","author":"R Frigerio","year":"2011","unstructured":"Frigerio R, Fujishiro H, Ahn TB, Josephs KA, Maraganore DM, Delledonne A, Parisi JE, Klos KJ, Boeve BF, Dickson DW, Ahlskog JE (2011) Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies? Neurobiol Aging 32:857\u2013863","journal-title":"Neurobiol Aging"},{"key":"1821_CR149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gaitpost.2016.08.009","volume":"50","author":"NE Fritz","year":"2016","unstructured":"Fritz NE, Kegelmeyer DA, Kloos AD, Linder S, Park A, Kataki M, Adeli A, Agrawal P, Scharre DW, Kostyk SK (2016) Motor performance differentiates individuals with Lewy body dementia, Parkinson\u2019s and Alzheimer\u2019s disease. Gait Posture 50:1\u20137","journal-title":"Gait Posture"},{"key":"1821_CR150","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1212\/01.wnl.0000254458.17630.c5","volume":"68","author":"J Fuchs","year":"2007","unstructured":"Fuchs J, Nilsson C, Kachergus J, Munz M, Larsson EM, Schule B, Langston JW, Middleton FA, Ross OA, Hulihan M, Gasser T, Farrer MJ (2007) Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 68:916\u2013922","journal-title":"Neurology"},{"key":"1821_CR151","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/NEN.0b013e31817d7a1d","volume":"67","author":"H Fujishiro","year":"2008","unstructured":"Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Knopman DS, Petersen RC, Parisi JE, Dickson DW (2008) Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol 67:649\u2013656","journal-title":"J Neuropathol Exp Neurol"},{"key":"1821_CR152","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2010.09.036","volume":"486","author":"H Fujishiro","year":"2010","unstructured":"Fujishiro H, Iseki E, Higashi S, Kasanuki K, Murayama N, Togo T, Katsuse O, Uchikado H, Aoki N, Kosaka K, Arai H, Sato K (2010) Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia. Neurosci Lett 486:19\u201323","journal-title":"Neurosci Lett"},{"key":"1821_CR153","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/gps.2836","volume":"27","author":"H Fujishiro","year":"2012","unstructured":"Fujishiro H, Iseki E, Kasanuki K, Murayama N, Ota K, Suzuki M, Sato K (2012) Glucose hypometabolism in primary visual cortex is commonly associated with clinical features of dementia with Lewy bodies regardless of cognitive conditions. Int J Geriatr Psychiatry 27:1138\u20131146","journal-title":"Int J Geriatr Psychiatry"},{"key":"1821_CR154","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.20688","volume":"59","author":"M Fujita","year":"2006","unstructured":"Fujita M, Ichise M, Zoghbi SS, Liow JS, Ghose S, Vines DC, Sangare J, Lu JQ, Cropley VL, Iida H, Kim KM, Cohen RM, Bara-Jimenez W, Ravina B, Innis RB (2006) Widespread decrease of nicotinic acetylcholine receptors in Parkinson\u2019s disease. Ann Neurol 59:174\u2013177","journal-title":"Ann Neurol"},{"key":"1821_CR155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000351423","volume":"3","author":"T Fukui","year":"2013","unstructured":"Fukui T, Oowan Y, Yamazaki T, Kinno R (2013) 2012- Prevalence and clinical implication of microbleeds in dementia with Lewy bodies in comparison with microbleeds in Alzheimer\u2019s disease. Dement Geriatr Cogn Dis Extra 3:148\u2013160","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"1821_CR156","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ana.21680","volume":"66","author":"JF Gagnon","year":"2009","unstructured":"Gagnon JF, Vendette M, Postuma RB, Desjardins C, Massicotte-Marquez J, Panisset M, Montplaisir J (2009) Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson\u2019s disease. Ann Neurol 66:39\u201347","journal-title":"Ann Neurol"},{"key":"1821_CR157","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/mds.23506","volume":"26","author":"C Gaig","year":"2011","unstructured":"Gaig C, Valldeoriola F, Gelpi E, Ezquerra M, Llufriu S, Buongiorno M, Rey MJ, Marti MJ, Graus F, Tolosa E (2011) Rapidly progressive diffuse Lewy body disease. Mov Disord 26:1316\u20131323","journal-title":"Mov Disord"},{"key":"1821_CR158","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ncl.2017.01.004","volume":"35","author":"D Galasko","year":"2017","unstructured":"Galasko D (2017) Lewy body disorders. Neurol Clin 35:325\u2013338","journal-title":"Neurol Clin"},{"key":"1821_CR159","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1212\/01.wnl.0000242630.52203.8f","volume":"67","author":"JE Galvin","year":"2006","unstructured":"Galvin JE, Pollack J, Morris JC (2006) Clinical phenotype of Parkinson disease dementia. Neurology 67:1605\u20131611","journal-title":"Neurology"},{"key":"1821_CR160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fneur.2017.00089","volume":"8","author":"P Garcia-Esparcia","year":"2017","unstructured":"Garcia-Esparcia P, Lopez-Gonzalez I, Grau-Rivera O, Garcia-Garrido MF, Konetti A, Llorens F, Zafar S, Carmona M, Del Rio JA, Zerr I, Gelpi E, Ferrer I (2017) Dementia with Lewy bodies: molecular pathology in the frontal cortex in typical and rapidly progressive forms. Front Neurol 8:89","journal-title":"Front Neurol"},{"key":"1821_CR161","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00702-017-1699-6","volume":"124","author":"H Garn","year":"2017","unstructured":"Garn H, Coronel C, Waser M, Caravias G, Ransmayr G (2017) Differential diagnosis between patients with probable Alzheimer\u2019s disease, Parkinson\u2019s disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features. J Neural Transm (Vienna) 124:569\u2013581","journal-title":"J Neural Transm (Vienna)"},{"issue":"Pt B","key":"1821_CR162","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neulet.2013.10.045","volume":"557","author":"AP Gatt","year":"2013","unstructured":"Gatt AP, Jones EL, Francis PT, Ballard C, Bateman JM (2013) Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson\u2019s disease dementia but not dementia with Lewy bodies. Neurosci Lett 557(Pt B):177\u2013180","journal-title":"Neurosci Lett"},{"key":"1821_CR163","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00415-016-8173-5","volume":"263","author":"S Gazzina","year":"2016","unstructured":"Gazzina S, Premi E, Turrone R, Acosta-Cabronero J, Rizzetti MC, Cotelli MS, Gasparotti R, Padovani A, Borroni B (2016) Subcortical matter in the alpha-synucleinopathies spectrum: an MRI pilot study. J Neurol 263:1575\u20131582","journal-title":"J Neurol"},{"key":"1821_CR164","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nbd.2016.06.004","volume":"94","author":"JT Geiger","year":"2016","unstructured":"Geiger JT, Ding J, Crain B, Pletnikova O, Letson C, Dawson TM, Rosenthal LS, Pantelyat A, Gibbs JR, Albert MS, Hernandez DG, Hillis AE, Stone DJ, Singleton AB, Hardy JA, Troncoso JC, Scholz SW (2016) Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies. Neurobiol Dis 94:55\u201362","journal-title":"Neurobiol Dis"},{"key":"1821_CR165","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/NEN.0b013e3181d88e63","volume":"69","author":"E Ghebremedhin","year":"2010","unstructured":"Ghebremedhin E, Rosenberger A, Rub U, Vuksic M, Berhe T, Bickeboller H, de Vos RA, Thal DR, Deller T (2010) Inverse relationship between cerebrovascular lesions and severity of Lewy body pathology in patients with lewy body diseases. J Neuropathol Exp Neurol 69:442\u2013448","journal-title":"J Neuropathol Exp Neurol"},{"key":"1821_CR166","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/brain\/aww230","volume":"140","author":"M Goedert","year":"2017","unstructured":"Goedert M, Masuda-Suzukake M, Falcon B (2017) Like prions: the propagation of aggregated tau and alpha-synuclein in neurodegeneration. Brain 140:266\u2013278","journal-title":"Brain"},{"issue":"Suppl 2","key":"1821_CR167","first-page":"S81","volume":"64","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Emre M, Dubois B (2008) Parkinson\u2019s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 64(Suppl 2):S81\u2013S92","journal-title":"Ann Neurol"},{"key":"1821_CR168","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/mds.22322","volume":"23","author":"JG Goldman","year":"2008","unstructured":"Goldman JG, Goetz CG, Brandabur M, Sanfilippo M, Stebbins GT (2008) Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies. Mov Disord 23:2248\u20132250","journal-title":"Mov Disord"},{"key":"1821_CR169","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mds.25866","volume":"29","author":"JG Goldman","year":"2014","unstructured":"Goldman JG, Williams-Gray C, Barker RA, Duda JE, Galvin JE (2014) The spectrum of cognitive impairment in Lewy body diseases. Mov Disord 29:608\u2013621","journal-title":"Mov Disord"},{"key":"1821_CR170","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000109756","volume":"16","author":"R Goldmann Gross","year":"2008","unstructured":"Goldmann Gross R, Siderowf A, Hurtig HI (2008) Cognitive impairment in Parkinson\u2019s disease and dementia with Lewy bodies: a spectrum of disease. Neurosignals 16:24\u201334","journal-title":"Neurosignals"},{"key":"1821_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2017.1009.1033","author":"DS Goldstein","year":"2017","unstructured":"Goldstein DS, Sharabi Y (2017) The heart of PD: Lewy body diseases as neurocardiologic disorders. Brain Res. https:\/\/doi.org\/10.1016\/j.brainres.2017.1009.1033","journal-title":"Brain Res"},{"key":"1821_CR172","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s11910-014-0472-6","volume":"14","author":"SN Gomperts","year":"2014","unstructured":"Gomperts SN (2014) Imaging the role of amyloid in PD dementia and dementia with Lewy bodies. Curr Neurol Neurosci Rep 14:472","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1821_CR173","first-page":"435","volume":"22","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN (2016) Lewy body dementias: dementia with Lewy bodies and Parkinson disease dementia. Continuum (Minneap Minn) 22:435\u2013463","journal-title":"Continuum (Minneap Minn)"},{"key":"1821_CR174","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","volume":"71","author":"SN Gomperts","year":"2008","unstructured":"Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, Mathis CA, Elmaleh DR, Shoup T, Fischman AJ, Hyman BT, Growdon JH, Johnson KA (2008) Imaging amyloid deposition in Lewy body diseases. Neurology 71:903\u2013910","journal-title":"Neurology"},{"key":"1821_CR175","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","volume":"73","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN, Locascio JJ, Makaretz SJ, Schultz A, Caso C, Vasdev N, Sperling R, Growdon JH, Dickerson BC, Johnson K (2016a) Tau positron emission tomographic imaging in the Lewy body diseases. JAMA Neurol 73:1334\u20131341","journal-title":"JAMA Neurol"},{"key":"1821_CR176","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000441421","volume":"16","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN, Marquie M, Locascio JJ, Bayer S, Johnson KA, Growdon JH (2016b) PET radioligands reveal the basis of dementia in Parkinson\u2019s disease and dementia with Lewy bodies. Neurodegener Dis 16:118\u2013124","journal-title":"Neurodegener Dis"},{"key":"1821_CR177","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.21192","volume":"62","author":"A Goris","year":"2007","unstructured":"Goris A, Williams-Gray CH, Clark GR, Foltynie T, Lewis SJ, Brown J, Ban M, Spillantini MG, Compston A, Burn DJ, Chinnery PF, Barker RA, Sawcer SJ (2007) Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson\u2019s disease. Ann Neurol 62:145\u2013153","journal-title":"Ann Neurol"},{"key":"1821_CR178","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/mds.26666","volume":"31","author":"J Graff-Radford","year":"2016","unstructured":"Graff-Radford J, Lesnick TG, Boeve BF, Przybelski SA, Jones DT, Senjem ML, Gunter JL, Ferman TJ, Knopman DS, Murray ME, Dickson DW, Sarro L, Jack CR Jr, Petersen RC, Kantarci K (2016a) Predicting survival in dementia with Lewy bodies with hippocampal volumetry. Mov Disord 31:989\u2013994","journal-title":"Mov Disord"},{"key":"1821_CR179","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jalz.2016.03.004","volume":"12","author":"NR Graff-Radford","year":"2016","unstructured":"Graff-Radford NR, Besser LM, Crook JE, Kukull WA, Dickson DW (2016b) Neuropathologic differences by race from the National Alzheimer\u2019s Coordinating Center. Alzheimers Dement 12:669\u2013677","journal-title":"Alzheimers Dement"},{"key":"1821_CR180","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jamaneurol.2016.4926","volume":"74","author":"J Graff-Radford","year":"2017","unstructured":"Graff-Radford J, Aakre J, Savica R, Boeve B, Kremers WK, Ferman TJ, Jones DT, Kantarci K, Knopman DS, Dickson DW, Kukull WA, Petersen RC (2017) Duration and pathologic correlates of Lewy body disease. JAMA Neurol 74:310\u2013315","journal-title":"JAMA Neurol"},{"key":"1821_CR181","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/ana.24664","volume":"79","author":"I Guella","year":"2016","unstructured":"Guella I, Evans DM, Szu-Tu C, Nosova E, Bortnick SF, Goldman JG, Dalrymple-Alford JC, Geurtsen GJ, Litvan I, Ross OA, Middleton LT, Parkkinen L, Farrer MJ (2016) alpha-synuclein genetic variability: a biomarker for dementia in Parkinson disease. Ann Neurol 79:991\u2013999","journal-title":"Ann Neurol"},{"key":"1821_CR182","first-page":"214","volume":"38","author":"R Guerreiro","year":"2016","unstructured":"Guerreiro R, Escott-Price V, Darwent L, Parkkinen L, Ansorge O, Hernandez DG, Nalls MA, Clark L, Honig L, Marder K, van der Flier W, Holstege H, Louwersheimer E, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns NJ, Halliday GM, Mann D, Pickering-Brown S, Powell J, Lunnon K, Lupton MK, Dickson D, Hardy J, Singleton A, Bras J (2016) Genome-wide analysis of genetic correlation in dementia with Lewy bodies. Parkinson\u2019s and Alzheimer\u2019s diseases. Neurobiol Aging 38:214","journal-title":"Parkinson\u2019s and Alzheimer\u2019s diseases. Neurobiol Aging"},{"key":"1821_CR183","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.parkreldis.2015.07.008","volume":"21","author":"I Gungor","year":"2015","unstructured":"Gungor I, Sarro L, Graff-Radford J, Zuk SM, Tosakulwong N, Przybelski SA, Lesnick T, Boeve BF, Ferman TJ, Smith GE, Knopman DS, Filippi M, Petersen RC, Jack CR Jr, Kantarci K (2015) Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer\u2019s disease. Parkinsonism Relat Disord 21:1101\u20131104","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR184","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","volume":"154","author":"JL Guo","year":"2013","unstructured":"Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, Riddle DM, Kwong LK, Xu Y, Trojanowski JQ, Lee VM (2013) Distinct alpha-synuclein strains differentially promote tau inclusions in neurons. Cell 154:103\u2013117","journal-title":"Cell"},{"key":"1821_CR185","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2217\/bmm-2016-0370","volume":"11","author":"K Gwinn","year":"2017","unstructured":"Gwinn K, David KK, Swanson-Fischer C, Albin R, Hillaire-Clarke CS, Sieber BA, Lungu C, Bowman FD, Alcalay RN, Babcock D, Dawson TM, Dewey RB Jr, Foroud T, German D, Huang X, Petyuk V, Potashkin JA, Saunders-Pullman R, Sutherland M, Walt DR, West AB, Zhang J, Chen-Plotkin A, Scherzer CR, Vaillancourt DE, Rosenthal LS (2017) Parkinson\u2019s disease biomarkers: perspective from the NINDS Parkinson\u2019s Disease Biomarkers Program. Biomark Med 11:451\u2013473","journal-title":"Biomark Med"},{"key":"1821_CR186","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1460-9568.2011.07660.x","volume":"33","author":"T Haggerty","year":"2011","unstructured":"Haggerty T, Credle J, Rodriguez O, Wills J, Oaks AW, Masliah E, Sidhu A (2011) Hyperphosphorylated tau in an alpha-synuclein-overexpressing transgenic model of Parkinson\u2019s disease. Eur J Neurosci 33:1598\u20131610","journal-title":"Eur J Neurosci"},{"key":"1821_CR187","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/brain\/awu193","volume":"137","author":"H Hall","year":"2014","unstructured":"Hall H, Reyes S, Landeck N, Bye C, Leanza G, Double K, Thompson L, Halliday G, Kirik D (2014) Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson\u2019s disease. Brain 137:2493\u20132508","journal-title":"Brain"},{"key":"1821_CR188","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.0000000000001098","volume":"84","author":"S Hall","year":"2015","unstructured":"Hall S, Surova Y, Ohrfelt A, Zetterberg H, Lindqvist D, Hansson O (2015) CSF biomarkers and clinical progression of Parkinson disease. Neurology 84:57\u201363","journal-title":"Neurology"},{"key":"1821_CR189","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00702-016-1528-3","volume":"123","author":"JM Hall","year":"2016","unstructured":"Hall JM, O\u2019Callaghan C, Shine JM, Muller AJ, Phillips JR, Walton CC, Lewis SJ, Moustafa AA (2016a) Dysfunction in attentional processing in patients with Parkinson\u2019s disease and visual hallucinations. J Neural Transm (Vienna) 123:503\u2013507","journal-title":"J Neural Transm (Vienna)"},{"key":"1821_CR190","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/mds.26578","volume":"31","author":"S Hall","year":"2016","unstructured":"Hall S, Surova Y, Ohrfelt A, Blennow K, Zetterberg H, Hansson O (2016b) Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson\u2019s disease. Mov Disord 31:898\u2013905","journal-title":"Mov Disord"},{"key":"1821_CR191","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","volume":"122","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Holton JL, Revesz T, Dickson DW (2011a) Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol 122:187\u2013204","journal-title":"Acta Neuropathol"},{"key":"1821_CR192","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00702-011-0641-6","volume":"118","author":"GM Halliday","year":"2011","unstructured":"Halliday GM, Song YJ, Harding AJ (2011b) Striatal beta-amyloid in dementia with Lewy bodies but not Parkinson\u2019s disease. J Neural Transm 118:713\u2013719","journal-title":"J Neural Transm"},{"key":"1821_CR193","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/mds.25857","volume":"29","author":"GM Halliday","year":"2014","unstructured":"Halliday GM, Leverenz JB, Schneider JS, Adler CH (2014) The neurobiological basis of cognitive impairment in Parkinson\u2019s disease. Mov Disord 29:634\u2013650","journal-title":"Mov Disord"},{"key":"1821_CR194","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/jnnp.64.5.653","volume":"64","author":"LA Hansen","year":"1998","unstructured":"Hansen LA, Daniel SE, Wilcock GK, Love S (1998) Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer\u2019s disease and dementia. J Neurol Neurosurg Psychiatry 64:653\u2013656","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/alzrt255","volume":"6","author":"O Hansson","year":"2014","unstructured":"Hansson O, Hall S, Ohrfelt A, Zetterberg H, Blennow K, Minthon L, Nagga K, Londos E, Varghese S, Majbour NK, Al-Hayani A, El-Agnaf OM (2014) Levels of cerebrospinal fluid alpha-synuclein oligomers are increased in Parkinson\u2019s disease with dementia and dementia with Lewy bodies compared to Alzheimer\u2019s disease. Alzheimers Res Ther 6:25","journal-title":"Alzheimers Res Ther"},{"key":"1821_CR196","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004010100390","volume":"102","author":"AJ Harding","year":"2001","unstructured":"Harding AJ, Halliday GM (2001) Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 102:355\u2013363","journal-title":"Acta Neuropathol"},{"key":"1821_CR197","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awf033","volume":"125","author":"AJ Harding","year":"2002","unstructured":"Harding AJ, Broe GA, Halliday GM (2002) Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125:391\u2013403","journal-title":"Brain"},{"key":"1821_CR198","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/jnnp-2016-314978","volume":"88","author":"L Harper","year":"2017","unstructured":"Harper L, Bouwman F, Burton EJ, Barkhof F, Scheltens P, O\u2019Brien JT, Fox NC, Ridgway GR, Schott JM (2017) Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis. J Neurol Neurosurg Psychiatry 88:908\u2013916","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR199","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.parkreldis.2016.07.015","volume":"31","author":"MG Heckman","year":"2016","unstructured":"Heckman MG, Soto-Ortolaza AI, Sanchez Contreras MY, Murray ME, Pedraza O, Diehl NN, Walton R, Labbe C, Lorenzo-Betancor O, Uitti RJ, van Gerpen J, Ertekin-Taner N, Smith GE, Kantarci K, Savica R, Jones DT, Graff-Radford J, Knopman DS, Lowe VJ, Jack CR Jr, Petersen RC, Parisi JE, Rademakers R, Wszolek ZK, Graff-Radford NR, Ferman TJ, Dickson DW, Boeve BF, Ross OA (2016) LRRK2 variation and dementia with Lewy bodies. Parkinsonism Relat Disord 31:98\u2013103","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR200","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2017.1009.1009","author":"MG Heckman","year":"2017","unstructured":"Heckman MG, Kasanuki K, Diehl NN, Koga S, Soto A, Murray ME, Dickson DW, Ross OA (2017) Parkinson's disease susceptibility variants and severity of Lewy body pathology. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.1009.1009","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR201","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13195-014-0091-0","volume":"7","author":"C Heitz","year":"2015","unstructured":"Heitz C, Noblet V, Cretin B, Philippi N, Kremer L, Stackfleth M, Hubele F, Armspach JP, Namer I, Blanc F (2015) Neural correlates of visual hallucinations in dementia with Lewy bodies. Alzheimers Res Ther 7:6","journal-title":"Alzheimers Res Ther"},{"key":"1821_CR202","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/jnnp.60.5.531","volume":"60","author":"MA Hely","year":"1996","unstructured":"Hely MA, Reid WG, Halliday GM, McRitchie DA, Leicester J, Joffe R, Brooks W, Broe GA, Morris JG (1996) Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 60:531\u2013538","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR203","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20\u00a0years. Mov Disord 23:837\u2013844","journal-title":"Mov Disord"},{"key":"1821_CR204","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/NEN.0000000000000014","volume":"72","author":"DH Hepp","year":"2013","unstructured":"Hepp DH, Ruiter AM, Galis Y, Voorn P, Rozemuller AJ, Berendse HW, Foncke EM, van de Berg WD (2013) Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients. J Neuropathol Exp Neurol 72:1162\u20131170","journal-title":"J Neuropathol Exp Neurol"},{"key":"1821_CR205","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnen\/nlw070","volume":"75","author":"DH Hepp","year":"2016","unstructured":"Hepp DH, Vergoossen DL, Huisman E, Lemstra AW, Berendse HW, Rozemuller AJ, Foncke EM, van de Berg WD (2016) Distribution and load of amyloid-beta pathology in Parkinson disease and dementia with Lewy bodies. J Neuropathol Exp Neurol 75:936\u2013945","journal-title":"J Neuropathol Exp Neurol"},{"key":"1821_CR206","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.brainres.2007.09.048","volume":"1184","author":"S Higashi","year":"2007","unstructured":"Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, Fujisawa K, Togo T, Katsuse O, Uchikado H, Furukawa Y, Kosaka K, Arai H (2007) Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer\u2019s disease and dementia with Lewy bodies. Brain Res 1184:284\u2013294","journal-title":"Brain Res"},{"key":"1821_CR207","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/gps.4261","volume":"30","author":"P Hobson","year":"2015","unstructured":"Hobson P, Meara J (2015) Mild cognitive impairment in Parkinson\u2019s disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort. Int J Geriatr Psychiatry 30:1048\u20131055","journal-title":"Int J Geriatr Psychiatry"},{"key":"1821_CR208","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neurobiolaging.2016.03.021","volume":"45","author":"K Hodges","year":"2016","unstructured":"Hodges K, Brewer SS, Labbe C, Soto-Ortolaza AI, Walton RL, Strongosky AJ, Uitti RJ, van Gerpen JA, Ertekin-Taner N, Kantarci K, Lowe VJ, Parisi JE, Savica R, Graff-Radford J, Jones DT, Knopman DS, Petersen RC, Murray ME, Graff-Radford NR, Ferman TJ, Dickson DW, Wszolek ZK, Boeve BF, Ross OA, Lorenzo-Betancor O (2016) RAB39B gene mutations are not a common cause of Parkinson\u2019s disease or dementia with Lewy bodies. Neurobiol Aging 45:107\u2013108","journal-title":"Neurobiol Aging"},{"issue":"Suppl 1","key":"1821_CR209","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1017\/cjn.2016.2","volume":"43","author":"DB Hogan","year":"2016","unstructured":"Hogan DB, Fiest KM, Roberts JI, Maxwell CJ, Dykeman J, Pringsheim T, Steeves T, Smith EE, Pearson D, Jette N (2016) The prevalence and incidence of dementia with Lewy bodies: a systematic review. Can J Neurol Sci 43(Suppl 1):S83\u2013S95","journal-title":"Can J Neurol Sci"},{"key":"1821_CR210","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/neup.12208","volume":"35","author":"T Homma","year":"2015","unstructured":"Homma T, Mochizuki Y, Takahashi K, Komori T (2015) Medial temporal regional argyrophilic grain as a possible important factor affecting dementia in Parkinson\u2019s disease. Neuropathology 35:441\u2013451","journal-title":"Neuropathology"},{"key":"1821_CR211","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bpa.12182","volume":"25","author":"DR Howlett","year":"2015","unstructured":"Howlett DR, Whitfield D, Johnson M, Attems J, O\u2019Brien JT, Aarsland D, Lai MK, Lee JH, Chen C, Ballard C, Hortobagyi T, Francis PT (2015) Regional multiple pathology scores are associated with cognitive decline in Lewy body dementias. Brain Pathol 25:401\u2013408","journal-title":"Brain Pathol"},{"key":"1821_CR212","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2047-9158-2-4","volume":"2","author":"Y Huang","year":"2013","unstructured":"Huang Y, Halliday G (2013) Can we clinically diagnose dementia with Lewy bodies yet? Transl Neurodegener 2:4","journal-title":"Transl Neurodegener"},{"key":"1821_CR213","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00259-003-1331-x","volume":"31","author":"WS Huang","year":"2004","unstructured":"Huang WS, Lee MS, Lin JC, Chen CY, Yang YW, Lin SZ, Wey SP (2004) Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging 31:155\u2013161","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1821_CR214","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archneur.63.2.189","volume":"63","author":"X Huang","year":"2006","unstructured":"Huang X, Chen P, Kaufer DI, Troster AI, Poole C (2006) Apolipoprotein E and dementia in Parkinson disease: a meta-analysis. Arch Neurol 63:189\u2013193","journal-title":"Arch Neurol"},{"key":"1821_CR215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/RLU.0000000000000620","volume":"40","author":"SH Huang","year":"2015","unstructured":"Huang SH, Chang CC, Lui CC, Chen NC, Lee CC, Wang PW, Jiang CF (2015) Cortical metabolic and nigrostriatal abnormalities associated with clinical stage-specific dementia with Lewy bodies. Clin Nucl Med 40:26\u201331","journal-title":"Clin Nucl Med"},{"key":"1821_CR216","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3233\/JPD-120151","volume":"3","author":"KS Hwang","year":"2013","unstructured":"Hwang KS, Beyer MK, Green AE, Chung C, Thompson PM, Janvin C, Larsen JP, Aarsland D, Apostolova LG (2013) Mapping cortical atrophy in Parkinson\u2019s disease patients with dementia. J Parkinsons Dis 3:69\u201376","journal-title":"J Parkinsons Dis"},{"key":"1821_CR217","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3233\/JAD-151000","volume":"52","author":"L Iaccarino","year":"2016","unstructured":"Iaccarino L, Marelli S, Iannaccone S, Magnani G, Ferini-Strambi L, Perani D (2016) Severe brain metabolic decreases associated with rem sleep behavior disorder in dementia with Lewy bodies. J Alzheimers Dis 52:989\u2013997","journal-title":"J Alzheimers Dis"},{"key":"1821_CR218","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12149-016-1076-9","volume":"30","author":"T Iizuka","year":"2016","unstructured":"Iizuka T, Kameyama M (2016) Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies. Ann Nucl Med 30:421\u2013429","journal-title":"Ann Nucl Med"},{"key":"1821_CR219","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pscychresns.2017.09.007","volume":"269","author":"T Iizuka","year":"2017","unstructured":"Iizuka T, Kameyama M (2017) Metabolic correlate of memory-deficit awareness in dementia with Lewy bodies: implication in cortical midline structure. Psychiatry Res 269:43\u201347","journal-title":"Psychiatry Res"},{"key":"1821_CR220","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13195-014-0083-0","volume":"7","author":"M Ikeda","year":"2015","unstructured":"Ikeda M, Mori E, Matsuo K, Nakagawa M, Kosaka K (2015) Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial. Alzheimers Res Ther 7:4","journal-title":"Alzheimers Res Ther"},{"key":"1821_CR221","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archneur.65.4.514","volume":"65","author":"T Ikeuchi","year":"2008","unstructured":"Ikeuchi T, Kakita A, Shiga A, Kasuga K, Kaneko H, Tan CF, Idezuka J, Wakabayashi K, Onodera O, Iwatsubo T, Nishizawa M, Takahashi H, Ishikawa A (2008) Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. Arch Neurol 65:514\u2013519","journal-title":"Arch Neurol"},{"key":"1821_CR222","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/9781444341256.ch22","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"PG Ince","year":"2011","unstructured":"Ince PG (2011) Dementia with Lewy bodies and Parkinson\u2019s disease dementia. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Blackwell, Oxford, pp 224\u2013237","edition":"2"},{"key":"1821_CR223","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.23659","volume":"72","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V, Lee VM, Leverenz JB, Montine TJ, Duda JE, Hurtig HI, Trojanowski JQ (2012) Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 72:587\u2013598","journal-title":"Ann Neurol"},{"key":"1821_CR224","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Lee VM, Trojanowski JQ (2013) Parkinson\u2019s disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies. Nat Rev Neurosci 14:626\u2013636","journal-title":"Nat Rev Neurosci"},{"key":"1821_CR225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, Leverenz JB, Tsuang D, Longfellow K, Yearout D, Kukull W, Keene CD, Montine TJ, Zabetian CP, Trojanowski JQ (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16:55\u201365","journal-title":"Lancet Neurol"},{"key":"1821_CR226","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00401-002-0644-3","volume":"105","author":"E Iseki","year":"2003","unstructured":"Iseki E, Togo T, Suzuki K, Katsuse O, Marui W, de Silva R, Lees A, Yamamoto T, Kosaka K (2003) Dementia with Lewy bodies from the perspective of tauopathy. Acta Neuropathol 105:265\u2013270","journal-title":"Acta Neuropathol"},{"key":"1821_CR227","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.parkreldis.2005.09.001","volume":"12","author":"KA Jellinger","year":"2006","unstructured":"Jellinger KA (2006) Pathological substrate of dementia in Parkinson\u2019s disease\u2013its relation to DLB and DLBD. Parkinsonism Relat Disord 12:119\u2013120","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR228","first-page":"267","volume-title":"Degenerative diseases of the nervous system","author":"KA Jellinger","year":"2007","unstructured":"Jellinger KA (2007a) Lewy body disorders. In: Youdim MBH, Riederer P, Mandel SA, Battistin L, Lajtha A (eds) Degenerative diseases of the nervous system. Springer, New York, pp 267\u2013343"},{"key":"1821_CR229","first-page":"91","volume":"Suppl","author":"KA Jellinger","year":"2007","unstructured":"Jellinger KA (2007b) Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study. J Neural Transm Suppl:91\u2013104","journal-title":"J Neural Transm"},{"key":"1821_CR230","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/01.wnl.0000304033.82293.9a","volume":"70","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) Re: in dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology 70:407\u2013408","journal-title":"Neurology"},{"key":"1821_CR231","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000197890","volume":"24","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009) Significance of brain lesions in Parkinson disease dementia and Lewy body dementia. Front Neurol Neurosci 24:114\u2013125","journal-title":"Front Neurol Neurosci"},{"key":"1821_CR232","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-009-0613-1","volume":"119","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010) The neuropathologic substrate of Parkinson disease dementia. Acta Neuropathol 119:151\u2013153","journal-title":"Acta Neuropathol"},{"key":"1821_CR233","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.expneurol.2010.10.006","volume":"227","author":"KA Jellinger","year":"2011","unstructured":"Jellinger KA (2011) Interaction between alpha-synuclein and tau in Parkinson\u2019s disease comment on Wills et al.: elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson\u2019s disease brains with and without dementia. Exp Neurol 2010; 225: 210\u2013218. Exp Neurol 227:13\u201318","journal-title":"Exp Neurol"},{"key":"1821_CR234","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1586\/ern.12.131","volume":"12","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012) Neurobiology of cognitive impairment in Parkinson\u2019s disease. Expert Rev Neurother 12:1451\u20131466","journal-title":"Expert Rev Neurother"},{"key":"1821_CR235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00702-012-0771-5","volume":"120","author":"KA Jellinger","year":"2013","unstructured":"Jellinger KA (2013) Mild cognitive impairment in Parkinson disease: heterogenous mechanisms. J Neural Transm 120:157\u2013167","journal-title":"J Neural Transm"},{"key":"1821_CR236","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-319-08046-8_2","volume-title":"Inflammation in Parkinson\u2019s disease: scientific and clinical aspects","author":"KA Jellinger","year":"2014","unstructured":"Jellinger KA (2014) Neuropathology of Parkinson\u2019s disease. In: Thomas M (ed) Inflammation in Parkinson\u2019s disease: scientific and clinical aspects. Springer, New York, pp 25\u201347"},{"key":"1821_CR237","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00401-006-0088-2","volume":"112","author":"KA Jellinger","year":"2006","unstructured":"Jellinger KA, Attems J (2006) Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol 112:253\u2013260","journal-title":"Acta Neuropathol"},{"key":"1821_CR238","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","volume":"115","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115:427\u2013436","journal-title":"Acta Neuropathol"},{"key":"1821_CR239","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000327360","volume":"31","author":"KA Jellinger","year":"2011","unstructured":"Jellinger KA, Attems J (2011) Prevalence and pathology of dementia with Lewy bodies in the oldest old: a comparison with other dementing disorders. Dement Geriatr Cogn Disord 31:309\u2013316","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1821_CR240","doi-asserted-by":"crossref","unstructured":"Jellinger KA, Korczyn A (2017) Are dementia with Lewy bodies and Parkinson\u2019s disease-dementia the same disease? BMC Med (submitted)","DOI":"10.1186\/s12916-018-1016-8"},{"key":"1821_CR241","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s007020200027","volume":"109","author":"KA Jellinger","year":"2002","unstructured":"Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson\u2019s disease. J Neural Transm 109:329\u2013339","journal-title":"J Neural Transm"},{"key":"1821_CR242","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000107703","volume":"4","author":"KA Jellinger","year":"2007","unstructured":"Jellinger KA, Wenning GK, Seppi K (2007) Predictors of survival in dementia with Lewy bodies and Parkinson dementia. Neurodegener Dis 4:428\u2013430","journal-title":"Neurodegener Dis"},{"key":"1821_CR243","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/bs.irn.2016.12.001","volume":"132","author":"I Johar","year":"2017","unstructured":"Johar I, Mollenhauer B, Aarsland D (2017) Cerebrospinal fluid biomarkers of cognitive decline in Parkinson\u2019s disease. Int Rev Neurobiol 132:275\u2013294","journal-title":"Int Rev Neurobiol"},{"key":"1821_CR244","doi-asserted-by":"crossref","unstructured":"Joki H, Higashiyama Y, Nakae Y, Kugimoto C, Doi H, Kimura K, Kishida H, Ueda N, Nakano T, Takahashi T, Koyano S, Takeuchi H, Tanaka F (2017) White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson\u2019s disease with dementia, and Alzheimer\u2019s disease. J Neurol Sci (submitted)","DOI":"10.1016\/j.jns.2017.12.018"},{"key":"1821_CR245","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.parkreldis.2010.08.021","volume":"16","author":"P Jokinen","year":"2010","unstructured":"Jokinen P, Scheinin N, Aalto S, Nagren K, Savisto N, Parkkola R, Rokka J, Haaparanta M, Roytta M, Rinne JO (2010) [(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson\u2019s disease with and without dementia. Parkinsonism Relat Disord 16:666\u2013670","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR246","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.parkreldis.2014.04.019","volume":"20","author":"J Joutsa","year":"2014","unstructured":"Joutsa J, Gardberg M, Roytta M, Kaasinen V (2014) Diagnostic accuracy of Parkinsonism syndromes by general neurologists. Parkinsonism Relat Disord 20:840\u2013844","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR001","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25103","author":"V Kaasinen","year":"2017","unstructured":"Kaasinen V, Vahlberg T (2017) Striatal dopamine in Parkinson disease: a meta-analysis of imaging studies. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.25103","journal-title":"Ann Neurol"},{"key":"1821_CR247","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2009.05.083","volume":"461","author":"ME Kalaitzakis","year":"2009","unstructured":"Kalaitzakis ME, Pearce RK, Gentleman SM (2009) Clinical correlates of pathology in the claustrum in Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci Lett 461:12\u201315","journal-title":"Neurosci Lett"},{"key":"1821_CR248","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.nbd.2010.10.005","volume":"41","author":"ME Kalaitzakis","year":"2011","unstructured":"Kalaitzakis ME, Walls AJ, Pearce RK, Gentleman SM (2011) Striatal Abeta peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes. Neurobiol Dis 41:377\u2013384","journal-title":"Neurobiol Dis"},{"key":"1821_CR249","doi-asserted-by":"crossref","first-page":"89","DOI":"10.14802\/jmd.16017","volume":"9","author":"JH Kang","year":"2016","unstructured":"Kang JH (2016) Cerebrospinal fluid amyloid beta1\u201342, tau, and alpha-synuclein predict the heterogeneous progression of cognitive dysfunction in Parkinson\u2019s disease. J Mov Disord 9:89\u201396","journal-title":"J Mov Disord"},{"key":"1821_CR250","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2011.09.024","volume":"33","author":"K Kantarci","year":"2012","unstructured":"Kantarci K, Lowe VJ, Boeve BF, Weigand SD, Senjem ML, Przybelski SA, Dickson DW, Parisi JE, Knopman DS, Smith GE, Ferman TJ, Petersen RC, Jack CR Jr (2012) Multimodality imaging characteristics of dementia with Lewy bodies. Neurobiol Aging 33:2091\u20132105","journal-title":"Neurobiol Aging"},{"key":"1821_CR251","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.24825","volume":"81","author":"K Kantarci","year":"2017","unstructured":"Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG, Spychalla AJ, Gunter JL, Fields JA, Graff-Radford J, Ferman TJ, Jones DT, Murray ME, Knopman DS, Jack CR Jr, Petersen RC (2017) AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies. Ann Neurol 81:58\u201367","journal-title":"Ann Neurol"},{"key":"1821_CR252","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/WAD.0b013e3181b5065d","volume":"23","author":"AW Kao","year":"2009","unstructured":"Kao AW, Racine CA, Quitania LC, Kramer JH, Christine CW, Miller BL (2009) Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy. Alzheimer Dis Assoc Disord 23:365\u2013370","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1821_CR253","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","volume":"134","author":"A Kapasi","year":"2017","unstructured":"Kapasi A, DeCarli C, Schneider JA (2017) Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol 134:171\u2013186","journal-title":"Acta Neuropathol"},{"key":"1821_CR254","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jns.2011.10.010","volume":"314","author":"K Kasanuki","year":"2012","unstructured":"Kasanuki K, Iseki E, Fujishiro H, Yamamoto R, Higashi S, Minegishi M, Togo T, Katsuse O, Uchikado H, Furukawa Y, Hino H, Kosaka K, Sato K, Arai H (2012) Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies. J Neurol Sci 314:111\u2013119","journal-title":"J Neurol Sci"},{"key":"1821_CR255","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/mds.27184","volume":"32","author":"K Kasanuki","year":"2017","unstructured":"Kasanuki K, Heckman MG, Diehl NN, Murray ME, Koga S, Soto A, Ross OA, Dickson DW (2017) Regional analysis and genetic association of nigrostriatal degeneration in Lewy body disease. Mov Disord 32:1584\u20131593","journal-title":"Mov Disord"},{"key":"1821_CR256","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2202-12-79","volume":"12","author":"T Kaul","year":"2011","unstructured":"Kaul T, Credle J, Haggerty T, Oaks AW, Masliah E, Sidhu A (2011) Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson\u2019s disease. BMC Neurosci 12:79","journal-title":"BMC Neurosci"},{"key":"1821_CR257","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","volume":"9","author":"AA Kehagia","year":"2010","unstructured":"Kehagia AA, Barker RA, Robbins TW (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson\u2019s disease. Lancet Neurol 9:1200\u20131213","journal-title":"Lancet Neurol"},{"key":"1821_CR258","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/brain\/awq059","volume":"133","author":"PA Kempster","year":"2010","unstructured":"Kempster PA, O\u2019Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of Parkinson\u2019s disease: a clinico-pathological study. Brain 133:1755\u20131762","journal-title":"Brain"},{"key":"1821_CR259","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13195-014-0073-2","volume":"6","author":"WS Kim","year":"2014","unstructured":"Kim WS, Kagedal K, Halliday GM (2014) Alpha-synuclein biology in Lewy body diseases. Alzheimers Res Ther 6:73","journal-title":"Alzheimers Res Ther"},{"key":"1821_CR260","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3174\/ajnr.A4337","volume":"36","author":"SW Kim","year":"2015","unstructured":"Kim SW, Chung SJ, Oh YS, Yoon JH, Sunwoo MK, Hong JY, Kim JS, Lee PH (2015) Cerebral microbleeds in patients with dementia with Lewy bodies and Parkinson disease dementia. AJNR Am J Neuroradiol 36:1642\u20131647","journal-title":"AJNR Am J Neuroradiol"},{"key":"1821_CR261","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/JAD-160597","volume":"55","author":"Y Kim","year":"2017","unstructured":"Kim Y, Lee D, Cho KH, Lee JJ, Ham JH, Ye BS, Lee SK, Lee JM, Sohn YH, Lee PH (2017) Cognitive and neuroanatomical correlates in early versus late onset Parkinson\u2019s disease dementia. J Alzheimers Dis 55:485\u2013495","journal-title":"J Alzheimers Dis"},{"key":"1821_CR262","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/mds.23659","volume":"26","author":"AE King","year":"2011","unstructured":"King AE, Mintz J, Royall DR (2011) Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. Mov Disord 26:1218\u20131224","journal-title":"Mov Disord"},{"key":"1821_CR263","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00234-013-1199-9","volume":"55","author":"S Kitao","year":"2013","unstructured":"Kitao S, Matsusue E, Fujii S, Miyoshi F, Kaminou T, Kato S, Ito H, Ogawa T (2013) Correlation between pathology and neuromelanin MR imaging in Parkinson\u2019s disease and dementia with Lewy bodies. Neuroradiology 55:947\u2013953","journal-title":"Neuroradiology"},{"key":"1821_CR264","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2007.07.017","volume":"264","author":"M Kitayama","year":"2008","unstructured":"Kitayama M, Wada-Isoe K, Irizawa Y, Nakashima K (2008) Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson\u2019s disease. J Neurol Sci 264:22\u201326","journal-title":"J Neurol Sci"},{"key":"1821_CR265","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1212\/WNL.0b013e3181d55f61","volume":"74","author":"JC Klein","year":"2010","unstructured":"Klein JC, Eggers C, Kalbe E, Weisenbach S, Hohmann C, Vollmar S, Baudrexel S, Diederich NJ, Heiss WD, Hilker R (2010) Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology 74:885\u2013892","journal-title":"Neurology"},{"key":"1821_CR266","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","volume":"11","author":"L Klingelhoefer","year":"2015","unstructured":"Klingelhoefer L, Reichmann H (2015) Pathogenesis of Parkinson disease\u2014the gut\u2013brain axis and environmental factors. Nat Rev Neurol 11:625\u2013636","journal-title":"Nat Rev Neurol"},{"key":"1821_CR267","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neurobiolaging.2017.08.020","volume":"60","author":"JH Ko","year":"2017","unstructured":"Ko JH, Katako A, Aljuaid M, Goertzen AL, Borys A, Hobson DE, Kim SM, Lee CS (2017) Distinct brain metabolic patterns separately associated with cognition, motor function, and aging in Parkinson\u2019s disease dementia. Neurobiol Aging 60:81\u201391","journal-title":"Neurobiol Aging"},{"issue":"Suppl 1","key":"1821_CR268","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.parkreldis.2015.09.007","volume":"22","author":"T Konno","year":"2016","unstructured":"Konno T, Ross OA, Puschmann A, Dickson DW, Wszolek ZK (2016) Autosomal dominant Parkinson\u2019s disease caused by SNCA duplications. Parkinsonism Relat Disord 22(Suppl 1):S1\u2013S6","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 1","key":"1821_CR269","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1016\/j.parkreldis.2015.09.053","volume":"22","author":"AD Korczyn","year":"2016","unstructured":"Korczyn AD (2016) Parkinson\u2019s and Alzheimer\u2019s diseases: focus on mild cognitive impairment. Parkinsonism Relat Disord 22(Suppl 1):S159\u2013S161","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR270","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12916-015-0534-x","volume":"13","author":"AD Korczyn","year":"2015","unstructured":"Korczyn AD, Hassin-Baer S (2015) Can the disease course in Parkinson\u2019s disease be slowed? BMC Med 13:295","journal-title":"BMC Med"},{"key":"1821_CR271","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain 136:2419\u20132431","journal-title":"Brain"},{"key":"1821_CR272","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archneurol.2012.1608","volume":"69","author":"PT Kotzbauer","year":"2012","unstructured":"Kotzbauer PT, Cairns NJ, Campbell MC, Willis AW, Racette BA, Tabbal SD, Perlmutter JS (2012) Pathologic accumulation of alpha-synuclein and Abeta in Parkinson disease patients with dementia. Arch Neurol 69:1326\u20131331","journal-title":"Arch Neurol"},{"key":"1821_CR273","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-012-0964-x","volume":"124","author":"GG Kovacs","year":"2012","unstructured":"Kovacs GG, Wagner U, Dumont B, Pikkarainen M, Osman AA, Streichenberger N, Leisser I, Verchere J, Baron T, Alafuzoff I, Budka H, Perret-Liaudet A, Lachmann I (2012) An antibody with high reactivity for disease-associated alpha-synuclein reveals extensive brain pathology. Acta Neuropathol 124:37\u201350","journal-title":"Acta Neuropathol"},{"key":"1821_CR274","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1750-3639.2011.00545.x","volume":"22","author":"CL Kragh","year":"2012","unstructured":"Kragh CL, Ubhi K, Wyss-Coray T, Masliah E (2012) Autophagy in dementias. Brain Pathol 22:99\u2013109","journal-title":"Brain Pathol"},{"key":"1821_CR275","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-161109","volume":"57","author":"MG Kramberger","year":"2017","unstructured":"Kramberger MG, Auestad B, Garcia-Ptacek S, Abdelnour C, Olmo JG, Walker Z, Lemstra AW, Londos E, Blanc F, Bonanni L, McKeith I, Winblad B, de Jong FJ, Nobili F, Stefanova E, Petrova M, Falup-Pecurariu C, Rektorova I, Bostantjopoulou S, Biundo R, Weintraub D, Aarsland D (2017) Long-term cognitive decline in dementia with Lewy bodies in a large multicenter, international cohort. J Alzheimers Dis 57:787\u2013795","journal-title":"J Alzheimers Dis"},{"key":"1821_CR276","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","volume":"27","author":"ML Kramer","year":"2007","unstructured":"Kramer ML, Schulz-Schaeffer WJ (2007) Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 27:1405\u20131410","journal-title":"J Neurosci"},{"key":"1821_CR277","doi-asserted-by":"crossref","first-page":"214 e213","DOI":"10.1016\/j.neurobiolaging.2016.08.023","volume":"49","author":"C Kun-Rodrigues","year":"2017","unstructured":"Kun-Rodrigues C, Ross OA, Orme T, Shepherd C, Parkkinen L, Darwent L, Hernandez D, Ansorge O, Clark LN, Honig LS, Marder K, Lemstra A, Scheltens P, van der Flier W, Louwersheimer E, Holstege H, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Trojanowski JQ, Serrano GE, Beach TG, Clarimon J, Lleo A, Morenas-Rodriguez E, Lesage S, Galasko D, Masliah E, Santana I, Diez M, Pastor P, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Stone DJ, Pickering-Brown S, Mann D, Dickson DW, Halliday GM, Singleton A, Guerreiro R, Bras J (2017) Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies. Neurobiol Aging 49:214 e213\u2013214 e215","journal-title":"Neurobiol Aging"},{"key":"1821_CR278","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/jnr.21352","volume":"85","author":"T Kurata","year":"2007","unstructured":"Kurata T, Kawarabayashi T, Murakami T, Miyazaki K, Morimoto N, Ohta Y, Takehisa Y, Nagai M, Ikeda M, Matsubara E, Westaway D, Hyslop PS, Harigaya Y, Kamiya T, Shoji M, Abe K (2007) Enhanced accumulation of phosphorylated alpha-synuclein in double transgenic mice expressing mutant beta-amyloid precursor protein and presenilin-1. J Neurosci Res 85:2246\u20132252","journal-title":"J Neurosci Res"},{"key":"1821_CR279","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jalz.2016.05.002","volume":"12","author":"C Labb\u00e8","year":"2016","unstructured":"Labb\u00e8 C, Heckman MG, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Murray ME, Allen M, Uitti RJ, Wszolek ZK, Smith GE, Kantarci K, Knopman DS, Lowe VJ, Jack CR Jr, Ertekin-Taner N, Hassan A, Savica R, Petersen RC, Parisi JE, Maraganore DM, Graff-Radford NR, Ferman TJ, Boeve BF, Dickson DW, Ross OA (2016) MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies. Alzheimers Dement 12:1297\u20131304","journal-title":"Alzheimers Dement"},{"key":"1821_CR280","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.nbd.2014.07.002","volume":"77","author":"JT Lamberts","year":"2015","unstructured":"Lamberts JT, Hildebrandt EN, Brundin P (2015) Spreading of alpha-synuclein in the face of axonal transport deficits in Parkinson\u2019s disease: a speculative synthesis. Neurobiol Dis 77:276\u2013283","journal-title":"Neurobiol Dis"},{"key":"1821_CR281","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-007-0336-0","volume":"115","author":"T Lashley","year":"2008","unstructured":"Lashley T, Holton JL, Gray E, Kirkham K, O\u2019Sullivan SS, Hilbig A, Wood NW, Lees AJ, Revesz T (2008) Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson\u2019s disease patients. Acta Neuropathol 115:417\u2013425","journal-title":"Acta Neuropathol"},{"key":"1821_CR282","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","volume":"322","author":"HA Lashuel","year":"2002","unstructured":"Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, Lansbury PT Jr (2002) Alpha-synuclein, especially the Parkinson\u2019s disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322:1089\u20131102","journal-title":"J Mol Biol"},{"key":"1821_CR283","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/jcbfm.2014.40","volume":"34","author":"CJ Heron Le","year":"2014","unstructured":"Le Heron CJ, Wright SL, Melzer TR, Myall DJ, MacAskill MR, Livingston L, Keenan RJ, Watts R, Dalrymple-Alford JC, Anderson TJ (2014) Comparing cerebral perfusion in Alzheimer\u2019s disease and Parkinson\u2019s disease dementia: an ASL-MRI study. J Cereb Blood Flow Metab 34:964\u2013970","journal-title":"J Cereb Blood Flow Metab"},{"key":"1821_CR284","first-page":"45","volume":"8","author":"AV Lebedev","year":"2014","unstructured":"Lebedev AV, Westman E, Simmons A, Lebedeva A, Siepel FJ, Pereira JB, Aarsland D (2014) Large-scale resting state network correlates of cognitive impairment in Parkinson\u2019s disease and related dopaminergic deficits. Front Syst Neurosci 8:45","journal-title":"Front Syst Neurosci"},{"key":"1821_CR285","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/mds.22858","volume":"25","author":"JE Lee","year":"2010","unstructured":"Lee JE, Park B, Song SK, Sohn YH, Park HJ, Lee PH (2010a) A comparison of gray and white matter density in patients with Parkinson\u2019s disease dementia and dementia with Lewy bodies using voxel-based morphometry. Mov Disord 25:28\u201334","journal-title":"Mov Disord"},{"key":"1821_CR286","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jnnp.2009.184747","volume":"81","author":"JE Lee","year":"2010","unstructured":"Lee JE, Park HJ, Park B, Song SK, Sohn YH, Lee JD, Lee PH (2010b) A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson\u2019s disease dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 81:320\u2013326","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR287","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27252","author":"SH Lee","year":"2017","unstructured":"Lee SH, Cho H, Choi JY, Lee JH, Ryu YH, Lee MS, Lyoo CH (2017) Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases. Mov Disord. https:\/\/doi.org\/10.1002\/mds.27252","journal-title":"Mov Disord"},{"issue":"Suppl 5","key":"1821_CR288","first-page":"S9","volume":"17","author":"AJ Lees","year":"2002","unstructured":"Lees AJ (2002) Parkinson\u2019s disease with dementia (PDD) is the same clinicopathological entity as dementia with Lewy bodies (DLB) (abstr). Mov Disord 17(Suppl 5):S9","journal-title":"Mov Disord"},{"key":"1821_CR289","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.26968","volume":"32","author":"S Lehericy","year":"2017","unstructured":"Lehericy S, Vaillancourt DE, Seppi K, Monchi O, Rektorova I, Antonini A, McKeown MJ, Masellis M, Berg D, Rowe JB, Lewis SJG, Williams-Gray CH, Tessitore A, Siebner HR (2017) The role of high-field magnetic resonance imaging in parkinsonian disorders: pushing the boundaries forward. Mov Disord 32:510\u2013525","journal-title":"Mov Disord"},{"key":"1821_CR290","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp-2016-313775","volume":"88","author":"AW Lemstra","year":"2017","unstructured":"Lemstra AW, de Beer MH, Teunissen CE, Schreuder C, Scheltens P, van der Flier WM, Sikkes SA (2017) Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 88:113\u2013118","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR291","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.parkreldis.2010.10.003","volume":"17","author":"JB Leverenz","year":"2011","unstructured":"Leverenz JB, Watson GS, Shofer J, Zabetian CP, Zhang J, Montine TJ (2011) Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 17:61\u201364","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR292","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/acn3.299","volume":"3","author":"NS Lim","year":"2016","unstructured":"Lim NS, Swanson CR, Cherng HR, Unger TL, Xie SX, Weintraub D, Marek K, Stern MB, Siderowf A, Trojanowski JQ, Chen-Plotkin AS (2016) Plasma EGF and cognitive decline in Parkinson\u2019s disease and Alzheimer\u2019s disease. Ann Clin Transl Neurol 3:346\u2013355","journal-title":"Ann Clin Transl Neurol"},{"key":"1821_CR293","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.parkreldis.2015.02.010","volume":"21","author":"CH Lin","year":"2015","unstructured":"Lin CH, Wu RM (2015) Biomarkers of cognitive decline in Parkinson\u2019s disease. Parkinsonism Relat Disord 21:431\u2013443","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR294","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","volume":"68","author":"CF Lippa","year":"2007","unstructured":"Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK (2007) DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68:812\u2013819","journal-title":"Neurology"},{"key":"1821_CR295","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ana.24781","volume":"80","author":"G Liu","year":"2016","unstructured":"Liu G, Boot B, Locascio JJ, Jansen IE, Winder-Rhodes S, Eberly S, Elbaz A, Brice A, Ravina B, van Hilten JJ, Cormier-Dequaire F, Corvol JC, Barker RA, Heutink P, Marinus J, Williams-Gray CH, Scherzer CR (2016) Specifically neuropathic Gaucher\u2019s mutations accelerate cognitive decline in Parkinson\u2019s. Ann Neurol 80:674\u2013685","journal-title":"Ann Neurol"},{"key":"1821_CR296","doi-asserted-by":"crossref","first-page":"e0171802","DOI":"10.1371\/journal.pone.0171802","volume":"12","author":"S Liu","year":"2017","unstructured":"Liu S, Wang XD, Wang Y, Shi Z, Cai L, Han T, Zhou Y, Wang X, Gao S, Ji Y (2017) Clinical and neuroimaging characteristics of Chinese dementia with Lewy bodies. PLoS One 12:e0171802","journal-title":"PLoS One"},{"key":"1821_CR297","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00415-016-8259-0","volume":"263","author":"F Llorens","year":"2016","unstructured":"Llorens F, Schmitz M, Varges D, Kruse N, Gotzmann N, Gmitterova K, Mollenhauer B, Zerr I (2016) Cerebrospinal alpha-synuclein in alpha-synuclein aggregation disorders: tau\/alpha-synuclein ratio as potential biomarker for dementia with Lewy bodies. J Neurol 263:2271\u20132277","journal-title":"J Neurol"},{"key":"1821_CR298","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1212\/WNL.56.5.643","volume":"56","author":"K Lobotesis","year":"2001","unstructured":"Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, McKeith IG, O\u2019Brien JT (2001) Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 56:643\u2013649","journal-title":"Neurology"},{"key":"1821_CR299","doi-asserted-by":"crossref","first-page":"5012129","DOI":"10.1155\/2017\/5012129","volume":"2017","author":"F Longhena","year":"2017","unstructured":"Longhena F, Faustini G, Missale C, Pizzi M, Spano P, Bellucci A (2017) The contribution of alpha-synuclein spreading to Parkinson\u2019s disease synaptopathy. Neural Plast 2017:5012129","journal-title":"Neural Plast"},{"key":"1821_CR300","doi-asserted-by":"crossref","first-page":"e0149349","DOI":"10.1371\/journal.pone.0149349","volume":"11","author":"W Maetzler","year":"2016","unstructured":"Maetzler W, Deleersnijder W, Hanssens V, Bernard A, Brockmann K, Marquetand J, Wurster I, Rattay TW, Roncoroni L, Schaeffer E, Lerche S, Apel A, Deuschle C, Berg D (2016) GDF15\/MIC1 and MMP9 cerebrospinal fluid levels in Parkinson\u2019s disease and Lewy body dementia. PLoS One 11:e0149349","journal-title":"PLoS One"},{"key":"1821_CR301","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/alzrt248","volume":"6","author":"E Mak","year":"2014","unstructured":"Mak E, Su L, Williams GB, O\u2019Brien JT (2014) Neuroimaging characteristics of dementia with Lewy bodies. Alzheimers Res Ther 6:18","journal-title":"Alzheimers Res Ther"},{"key":"1821_CR302","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11064-006-9140-9","volume":"31","author":"PK Mandal","year":"2006","unstructured":"Mandal PK, Pettegrew JW, Masliah E, Hamilton RL, Mandal R (2006) Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer\u2019s and Parkinson\u2019s in dementia with Lewy body disease. Neurochem Res 31:1153\u20131162","journal-title":"Neurochem Res"},{"issue":"Suppl 1","key":"1821_CR303","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1002\/mds.22787","volume":"25","author":"K Marder","year":"2010","unstructured":"Marder K (2010) Cognitive impairment and dementia in Parkinson\u2019s disease. Mov Disord 25(Suppl 1):S110\u2013S116","journal-title":"Mov Disord"},{"key":"1821_CR304","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrn1199","volume":"4","author":"E Maries","year":"2003","unstructured":"Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K (2003) The role of alpha-synuclein in Parkinson\u2019s disease: insights from animal models. Nat Rev Neurosci 4:727\u2013738","journal-title":"Nat Rev Neurosci"},{"key":"1821_CR305","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13195-014-0052-7","volume":"6","author":"M Marquie","year":"2014","unstructured":"Marquie M, Locascio JJ, Rentz DM, Becker JA, Hedden T, Johnson KA, Growdon JH, Gomperts SN (2014) Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study. Alzheimers Res Ther 6:52","journal-title":"Alzheimers Res Ther"},{"key":"1821_CR306","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40478-017-0482-0","volume":"5","author":"M Marquie","year":"2017","unstructured":"Marquie M, Verwer EE, Meltzer AC, Kim SJW, Aguero C, Gonzalez J, Makaretz SJ, Siao Tick Chong M, Ramanan P, Amaral AC, Normandin MD, Vanderburg CR, Gomperts SN, Johnson KA, Frosch MP, Gomez-Isla T (2017) Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson\u2019s case. Acta Neuropathol Commun 5:75","journal-title":"Acta Neuropathol Commun"},{"key":"1821_CR307","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.parkreldis.2011.05.017","volume":"17","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P, Falup-Pecurariu C, Rodriguez-Blazquez C, Serrano-Duenas M, Carod Artal FJ, Rojo Abuin JM, Aarsland D (2011) Dementia associated with Parkinson\u2019s disease: applying the Movement Disorder Society Task Force criteria. Parkinsonism Relat Disord 17:621\u2013624","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR308","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JAD-2001-3117","volume":"3","author":"E Masliah","year":"2001","unstructured":"Masliah E (2001) Recent advances in the understanding of the role of synaptic proteins in Alzheimer\u2019s Disease and other neurodegenerative disorders. J Alzheimers Dis 3:121\u2013129","journal-title":"J Alzheimers Dis"},{"key":"1821_CR309","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1073\/pnas.211412398","volume":"98","author":"E Masliah","year":"2001","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L (2001) beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer\u2019s disease and Parkinson\u2019s disease. Proc Natl Acad Sci USA 98:12245\u201312250","journal-title":"Proc Natl Acad Sci USA"},{"key":"1821_CR310","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","volume":"71","author":"IF Mata","year":"2014","unstructured":"Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Hurtig HI, Van Deerlin VM, Ritz B, Rausch R, Rhodes SL, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson AL, Espay AJ, Revilla FJ, Devoto J, Hu SC, Cholerton BA, Wan JY, Montine TJ, Edwards KL, Zabetian CP (2014) APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. JAMA Neurol 71:1405\u20131412","journal-title":"JAMA Neurol"},{"key":"1821_CR311","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/mds.26359","volume":"31","author":"IF Mata","year":"2016","unstructured":"Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Goldman JG, Stebbins GT, Bernard B, Espay AJ, Revilla FJ, Devoto J, Rosenthal LS, Dawson TM, Albert MS, Tsuang D, Huston H, Yearout D, Hu SC, Cholerton BA, Montine TJ, Edwards KL, Zabetian CP (2016) GBA variants are associated with a distinct pattern of cognitive deficits in Parkinson\u2019s disease. Mov Disord 31:95\u2013102","journal-title":"Mov Disord"},{"key":"1821_CR312","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s004010051064","volume":"98","author":"PM Mattila","year":"1999","unstructured":"Mattila PM, Rinne JO, Helenius H, Roytta M (1999) Neuritic degeneration in the hippocampus and amygdala in Parkinson\u2019s disease in relation to Alzheimer pathology. Acta Neuropathol (Berl) 98:157\u2013164","journal-title":"Acta Neuropathol (Berl)"},{"key":"1821_CR313","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/bpa.12424","volume":"27","author":"KE McAleese","year":"2017","unstructured":"McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J (2017) TDP-43 pathology in Alzheimer\u2019s disease, dementia with Lewy bodies and ageing. Brain Pathol 27:472\u2013479","journal-title":"Brain Pathol"},{"key":"1821_CR314","first-page":"CD010633","volume":"1","author":"J McCleery","year":"2015","unstructured":"McCleery J, Morgan S, Bradley KM, Noel-Storr AH, Ansorge O, Hyde C (2015) Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies. Cochrane Database Syst Rev 1:CD010633","journal-title":"Cochrane Database Syst Rev"},{"key":"1821_CR315","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610217002265","author":"KL McDermott","year":"2017","unstructured":"McDermott KL, Fisher N, Bradford S, Camicioli R (2017) Parkinson\u2019s disease mild cognitive impairment classifications and neurobehavioral symptoms. Int Psychogeriatr. https:\/\/doi.org\/10.1017\/S1041610217002265","journal-title":"Int Psychogeriatr"},{"key":"1821_CR316","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/jnnp.2007.134163","volume":"7","author":"I McKeith","year":"2007","unstructured":"McKeith I (2007) Dementia with Lewy bodies and Parkinson\u2019s disease with dementia: where two worlds collide. Pract Neurol 7:374\u2013382","journal-title":"Pract Neurol"},{"key":"1821_CR317","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1017\/S1041610208008624","volume":"21","author":"I McKeith","year":"2009","unstructured":"McKeith I (2009) Commentary: DLB and PDD: the same or different? Is there a debate? Int Psychogeriatr 21:220\u2013224","journal-title":"Int Psychogeriatr"},{"issue":"Suppl 1","key":"1821_CR318","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.parkreldis.2003.12.005","volume":"10","author":"IG McKeith","year":"2004","unstructured":"McKeith IG, Mosimann UP (2004) Dementia with Lewy bodies and Parkinson\u2019s disease. Parkinsonism Relat Disord 10(Suppl 1):S15\u2013S18","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR319","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863\u20131872","journal-title":"Neurology"},{"key":"1821_CR320","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","volume":"6","author":"I McKeith","year":"2007","unstructured":"McKeith I, O\u2019Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, Padovani A, Giubbini R, Bonuccelli U, Volterrani D, Holmes C, Kemp P, Tabet N, Meyer I, Reininger C (2007) Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 6:305\u2013313","journal-title":"Lancet Neurol"},{"key":"1821_CR321","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/0891988716656083","volume":"29","author":"I McKeith","year":"2016","unstructured":"McKeith I, Taylor JP, Thomas A, Donaghy P, Kane J (2016) Revisiting DLB diagnosis: a consideration of prodromal DLB and of the diagnostic overlap with Alzheimer disease. J Geriatr Psychiatry Neurol 29:249\u2013253","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"1821_CR322","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O\u2019Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88\u2013100","journal-title":"Neurology"},{"key":"1821_CR323","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fneur.2012.00088","volume":"3","author":"J Meireles","year":"2012","unstructured":"Meireles J, Massano J (2012) Cognitive impairment and dementia in Parkinson\u2019s disease: clinical features, diagnosis, and management. Front Neurol 3:88","journal-title":"Front Neurol"},{"key":"1821_CR324","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.parkreldis.2016.04.013","volume":"29","author":"D Mengel","year":"2016","unstructured":"Mengel D, Dams J, Ziemek J, Becker J, Balzer-Geldsetzer M, Hilker R, Baudrexel S, Kalbe E, Schmidt N, Witt K, Liepelt-Scarfone I, Graber S, Petrelli A, Neuser P, Schulte C, Linse K, Storch A, Wittchen HU, Riedel O, Mollenhauer B, Ebentheuer J, Trenkwalder C, Klockgether T, Spottke A, Wullner U, Schulz JB, Reetz K, Heber IA, Ramirez A, Dodel R (2016) Apolipoprotein E epsilon4 does not affect cognitive performance in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 29:112\u2013116","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR325","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/mds.22270","volume":"23","author":"AM Meppelink","year":"2008","unstructured":"Meppelink AM, Koerts J, Borg M, Leenders KL, van Laar T (2008) Visual object recognition and attention in Parkinson\u2019s disease patients with visual hallucinations. Mov Disord 23:1906\u20131912","journal-title":"Mov Disord"},{"key":"1821_CR326","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.2967\/jnumed.116.186403","volume":"58","author":"PT Meyer","year":"2017","unstructured":"Meyer PT, Frings L, Rucker G, Hellwig S (2017) 18F-FDG PET in parkinsonism: differential diagnosis and cognitive impairment in parkinson's disease. J Nucl Med 58:1888\u20131898","journal-title":"J Nucl Med"},{"key":"1821_CR327","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/bpa.12297","volume":"26","author":"Y Miki","year":"2016","unstructured":"Miki Y, Tanji K, Mori F, Utsumi J, Sasaki H, Kakita A, Takahashi H, Wakabayashi K (2016) Alteration of upstream autophagy-related proteins (ULK1, ULK2, Beclin1, VPS34 and AMBRA1) in Lewy body disease. Brain Pathol 26:359\u2013370","journal-title":"Brain Pathol"},{"key":"1821_CR328","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1126\/science.aaf3934","volume":"357","author":"S Mittal","year":"2017","unstructured":"Mittal S, Bjornevik K, Im DS, Flierl A, Dong X, Locascio JJ, Abo KM, Long E, Jin M, Xu B, Xiang YK, Rochet JC, Engeland A, Rizzu P, Heutink P, Bartels T, Selkoe DJ, Caldarone BJ, Glicksman MA, Khurana V, Schule B, Park DS, Riise T, Scherzer CR (2017) Beta2-adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson\u2019s disease. Science 357:891\u2013898","journal-title":"Science"},{"issue":"Suppl 1","key":"1821_CR329","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/jnc.13390","volume":"139","author":"B Mollenhauer","year":"2016","unstructured":"Mollenhauer B, Parnetti L, Rektorova I, Kramberger MG, Pikkarainen M, Schulz-Schaeffer WJ, Aarsland D, Svenningsson P, Farotti L, Verbeek MM, Schlossmacher MG (2016) Biological confounders for the values of cerebrospinal fluid proteins in Parkinson\u2019s disease and related disorders. J Neurochem 139(Suppl 1):290\u2013317","journal-title":"J Neurochem"},{"key":"1821_CR330","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.2004.052332","volume":"76","author":"S Molloy","year":"2005","unstructured":"Molloy S, McKeith IG, O\u2019Brien JT, Burn DJ (2005) The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 76:1200\u20131203","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR331","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000447586","volume":"42","author":"E Mori","year":"2016","unstructured":"Mori E, Ikeda M, Nakagawa M, Miyagishi H, Kosaka K (2016) Pretreatment cognitive profile likely to benefit from donepezil treatment in dementia with Lewy bodies: pooled analyses of two randomized controlled trials. Dement Geriatr Cogn Disord 42:58\u201368","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1821_CR332","doi-asserted-by":"crossref","first-page":"e0171524","DOI":"10.1371\/journal.pone.0171524","volume":"12","author":"S Morimoto","year":"2017","unstructured":"Morimoto S, Takao M, Hatsuta H, Nishina Y, Komiya T, Sengoku R, Nakano Y, Uchino A, Sumikura H, Saito Y, Kanemaru K, Murayama S (2017) Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer\u2019s disease: an autopsy-confirmed study. PLoS One 12:e0171524","journal-title":"PLoS One"},{"key":"1821_CR333","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mds.24946","volume":"27","author":"JF Morley","year":"2012","unstructured":"Morley JF, Xie SX, Hurtig HI, Stern MB, Colcher A, Horn S, Dahodwala N, Duda JE, Weintraub D, Chen-Plotkin AS, Van Deerlin V, Falcone D, Siderowf A (2012) Genetic influences on cognitive decline in Parkinson\u2019s disease. Mov Disord 27:512\u2013518","journal-title":"Mov Disord"},{"key":"1821_CR334","first-page":"8","volume":"3","author":"UP Mosimann","year":"2003","unstructured":"Mosimann UP, McKeith I (2003) Dementia with Lewy bodies and Parkinson\u2019s disease dementia\u2014two synucleinopathies. ACNR 3:8\u201310","journal-title":"ACNR"},{"key":"1821_CR335","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/brain\/awh484","volume":"128","author":"UP Mosimann","year":"2005","unstructured":"Mosimann UP, Muri RM, Burn DJ, Felblinger J, O\u2019Brien JT, McKeith IG (2005) Saccadic eye movement changes in Parkinson\u2019s disease dementia and dementia with Lewy bodies. Brain 128:1267\u20131276","journal-title":"Brain"},{"key":"1821_CR336","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1474-4422(17)30074-1","volume":"16","author":"C Mueller","year":"2017","unstructured":"Mueller C, Ballard C, Corbett A, Aarsland D (2017) The prognosis of dementia with Lewy bodies. Lancet Neurol 16:390\u2013398","journal-title":"Lancet Neurol"},{"key":"1821_CR337","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/NEN.0b013e31827c5710","volume":"72","author":"EB Mukaetova-Ladinska","year":"2013","unstructured":"Mukaetova-Ladinska EB, Andras A, Milne J, Abdel-All Z, Borr I, Jaros E, Perry RH, Honer WG, Cleghorn A, Doherty J, McIntosh G, Perry EK, Kalaria RN, McKeith IG (2013) Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies. J Neuropathol Exp Neurol 72:53\u201360","journal-title":"J Neuropathol Exp Neurol"},{"key":"1821_CR338","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","volume":"114","author":"H Nakashima-Yasuda","year":"2007","unstructured":"Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, Masliah E, Kaye J, Clark CM, Montine TJ, Lee VM, Trojanowski JQ (2007) Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 114:221\u2013229","journal-title":"Acta Neuropathol"},{"key":"1821_CR339","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","volume":"70","author":"MA Nalls","year":"2013","unstructured":"Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, Morris CM, Theuns J, Crosiers D, Cras P, Engelborghs S, De Deyn PP, Van Broeckhoven C, Mann DM, Snowden J, Pickering-Brown S, Halliwell N, Davidson Y, Gibbons L, Harris J, Sheerin UM, Bras J, Hardy J, Clark L, Marder K, Honig LS, Berg D, Maetzler W, Brockmann K, Gasser T, Novellino F, Quattrone A, Annesi G, De Marco EV, Rogaeva E, Masellis M, Black SE, Bilbao JM, Foroud T, Ghetti B, Nichols WC, Pankratz N, Halliday G, Lesage S, Klebe S, Durr A, Duyckaerts C, Brice A, Giasson BI, Trojanowski JQ, Hurtig HI, Tayebi N, Landazabal C, Knight MA, Keller M, Singleton AB, Wolfsberg TG, Sidransky E (2013) A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol 70:727\u2013735","journal-title":"JAMA Neurol"},{"key":"1821_CR340","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.freeradbiomed.2009.03.007","volume":"46","author":"A Navarro","year":"2009","unstructured":"Navarro A, Boveris A, Bandez MJ, Sanchez-Pino MJ, Gomez C, Muntane G, Ferrer I (2009) Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies. Free Radic Biol Med 46:1574\u20131580","journal-title":"Free Radic Biol Med"},{"key":"1821_CR341","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neurobiolaging.2014.07.005","volume":"36","author":"Z Nedelska","year":"2015","unstructured":"Nedelska Z, Ferman TJ, Boeve BF, Przybelski SA, Lesnick TG, Murray ME, Gunter JL, Senjem ML, Vemuri P, Smith GE, Geda YE, Graff-Radford J, Knopman DS, Petersen RC, Parisi JE, Dickson DW, Jack CR Jr, Kantarci K (2015) Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol Aging 36:452\u2013461","journal-title":"Neurobiol Aging"},{"key":"1821_CR342","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00415-009-5324-y","volume":"257","author":"PT Nelson","year":"2010","unstructured":"Nelson PT, Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G, Xu LO, Smith CD, Markesbery WR (2010) Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol 257:359\u2013366","journal-title":"J Neurol"},{"key":"1821_CR343","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2013.02.024","volume":"541","author":"K Nie","year":"2013","unstructured":"Nie K, Zhang Y, Gan R, Wang L, Zhao J, Huang Z, Tang H (2013) Polymorphisms in immune\/inflammatory cytokine genes are related to Parkinson\u2019s disease with cognitive impairment in the Han Chinese population. Neurosci Lett 541:111\u2013115","journal-title":"Neurosci Lett"},{"key":"1821_CR344","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3233\/JAD-132246","volume":"40","author":"HM Nielsen","year":"2014","unstructured":"Nielsen HM, Hall S, Surova Y, Nagga K, Nilsson C, Londos E, Minthon L, Hansson O, Wennstrom M (2014) Low levels of soluble NG2 in cerebrospinal fluid from patients with dementia with Lewy bodies. J Alzheimers Dis 40:343\u2013350","journal-title":"J Alzheimers Dis"},{"key":"1821_CR345","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/mds.10633","volume":"19","author":"E Noe","year":"2004","unstructured":"Noe E, Marder K, Bell KL, Jacobs DM, Manly JJ, Stern Y (2004) Comparison of dementia with Lewy bodies to Alzheimer\u2019s disease and Parkinson\u2019s disease with dementia. Mov Disord 19:60\u201367","journal-title":"Mov Disord"},{"key":"1821_CR346","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/brain\/awu201","volume":"137","author":"C Nombela","year":"2014","unstructured":"Nombela C, Rowe JB, Winder-Rhodes SE, Hampshire A, Owen AM, Breen DP, Duncan GW, Khoo TK, Yarnall AJ, Firbank MJ, Chinnery PF, Robbins TW, O\u2019Brien JT, Brooks DJ, Burn DJ, Barker RA (2014) Genetic impact on cognition and brain function in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study. Brain 137:2743\u20132758","journal-title":"Brain"},{"key":"1821_CR347","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2017.10.017","volume":"299","author":"N Nouraei","year":"2017","unstructured":"Nouraei N, Mason DM, Miner KM, Carcella MA, Bhatia TN, Dumm BK, Soni D, Johnson DA, Luk KC, Leak RK (2017) Critical appraisal of pathology transmission in the alpha-synuclein fibril model of Lewy body disorders. Exp Neurol 299:172\u2013196","journal-title":"Exp Neurol"},{"key":"1821_CR348","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a024109","author":"RL Nussbaum","year":"2017","unstructured":"Nussbaum RL (2017) Genetics of synucleinopathies. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a024109","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1821_CR349","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.expneurol.2007.11.019","volume":"210","author":"K Obi","year":"2008","unstructured":"Obi K, Akiyama H, Kondo H, Shimomura Y, Hasegawa M, Iwatsubo T, Mizuno Y, Mochizuki H (2008) Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies. Exp Neurol 210:409\u2013420","journal-title":"Exp Neurol"},{"key":"1821_CR350","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2967\/jnumed.114.143347","volume":"55","author":"JT O\u2019Brien","year":"2014","unstructured":"O\u2019Brien JT, Firbank MJ, Davison C, Barnett N, Bamford C, Donaldson C, Olsen K, Herholz K, Williams D, Lloyd J (2014) 18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias. J Nucl Med 55:1959\u20131965","journal-title":"J Nucl Med"},{"key":"1821_CR351","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JAD-2009-1169","volume":"18","author":"M Oinas","year":"2009","unstructured":"Oinas M, Polvikoski T, Sulkava R, Myllykangas L, Juva K, Notkola IL, Rastas S, Niinisto L, Kalimo H, Paetau A (2009) Neuropathologic findings of dementia with Lewy bodies (DLB) in a population-based Vantaa 85+\u00a0study. J Alzheimers Dis 18:677\u2013689","journal-title":"J Alzheimers Dis"},{"key":"1821_CR352","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1212\/WNL.0000000000001020","volume":"83","author":"KT Olde Dubbelink","year":"2014","unstructured":"Olde Dubbelink KT, Schoonheim MM, Deijen JB, Twisk JW, Barkhof F, Berendse HW (2014) Functional connectivity and cognitive decline over 3\u00a0years in Parkinson disease. Neurology 83:2046\u20132053","journal-title":"Neurology"},{"key":"1821_CR353","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5692\/clinicalneurol.48.11","volume":"48","author":"S Orimo","year":"2008","unstructured":"Orimo S (2008) Clinical and pathological study on early diagnosis of Parkinson\u2019s disease and dementia with Lewy bodies. Rinsho Shinkeigaku 48:11\u201324","journal-title":"Rinsho Shinkeigaku"},{"key":"1821_CR354","first-page":"403","volume":"64","author":"S Orimo","year":"2012","unstructured":"Orimo S (2012) The clinical significance of MIBG myocardial scintigraphy in Parkinson disease. Brain Nerve 64:403\u2013412","journal-title":"Brain Nerve"},{"key":"1821_CR355","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.arr.2016.01.001","volume":"30","author":"S Orimo","year":"2016","unstructured":"Orimo S, Yogo M, Nakamura T, Suzuki M, Watanabe H (2016) (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in alpha-synucleinopathies. Ageing Res Rev 30:122\u2013133","journal-title":"Ageing Res Rev"},{"key":"1821_CR356","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-9-18","volume":"9","author":"CR Overk","year":"2014","unstructured":"Overk CR, Cartier A, Shaked G, Rockenstein E, Ubhi K, Spencer B, Price DL, Patrick C, Desplats P, Masliah E (2014) Hippocampal neuronal cells that accumulate alpha-synuclein fragments are more vulnerable to Abeta oligomer toxicity via mGluR5\u2014implications for dementia with Lewy bodies. Mol Neurodegener 9:18","journal-title":"Mol Neurodegener"},{"key":"1821_CR357","doi-asserted-by":"crossref","first-page":"e54980","DOI":"10.1371\/journal.pone.0054980","volume":"8","author":"J Pagonabarraga","year":"2013","unstructured":"Pagonabarraga J, Corcuera-Solano I, Vives-Gilabert Y, Llebaria G, Garcia-Sanchez C, Pascual-Sedano B, Delfino M, Kulisevsky J, Gomez-Anson B (2013) Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson\u2019s disease. PLoS One 8:e54980","journal-title":"PLoS One"},{"key":"1821_CR358","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.26432","volume":"31","author":"J Pagonabarraga","year":"2016","unstructured":"Pagonabarraga J, Martinez-Horta S, Fernandez de Bobadilla R, Perez J, Ribosa-Nogue R, Marin J, Pascual-Sedano B, Garcia C, Gironell A, Kulisevsky J (2016) Minor hallucinations occur in drug-naive Parkinson\u2019s disease patients, even from the premotor phase. Mov Disord 31:45\u201352","journal-title":"Mov Disord"},{"key":"1821_CR359","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awn349","volume":"132","author":"KE Paleologou","year":"2009","unstructured":"Paleologou KE, Kragh CL, Mann DM, Salem SA, Al-Shami R, Allsop D, Hassan AH, Jensen PH, El-Agnaf OM (2009) Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain 132:1093\u20131101","journal-title":"Brain"},{"key":"1821_CR360","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-10017-13154-10078","author":"C Papagno","year":"2017","unstructured":"Papagno C, Trojano L (2017) Cognitive and behavioral disorders in Parkinson\u2019s disease: an update. I: cognitive impairments. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-10017-13154-10078","journal-title":"Neurol Sci"},{"key":"1821_CR361","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.parkreldis.2011.09.015","volume":"18","author":"ND Papathanasiou","year":"2012","unstructured":"Papathanasiou ND, Boutsiadis A, Dickson J, Bomanji JB (2012) Diagnostic accuracy of 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies. Parkinsonism Relat Disord 18:225\u2013229","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR362","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3988\/jcn.2011.7.1.19","volume":"7","author":"KW Park","year":"2011","unstructured":"Park KW, Kim HS, Cheon SM, Cha JK, Kim SH, Kim JW (2011) Dementia with Lewy bodies versus Alzheimer\u2019s disease and Parkinson\u2019s disease dementia: a comparison of cognitive profiles. J Clin Neurol 7:19\u201324","journal-title":"J Clin Neurol"},{"key":"1821_CR363","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fnagi.2014.00053","volume":"6","author":"L Parnetti","year":"2014","unstructured":"Parnetti L, Farotti L, Eusebi P, Chiasserini D, De Carlo C, Giannandrea D, Salvadori N, Lisetti V, Tambasco N, Rossi A, Majbour NK, El-Agnaf O, Calabresi P (2014) Differential role of CSF alpha-synuclein species, tau, and Abeta42 in Parkinson\u2019s Disease. Front Aging Neurosci 6:53","journal-title":"Front Aging Neurosci"},{"key":"1821_CR364","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.parkreldis.2016.07.008","volume":"31","author":"GM Peavy","year":"2016","unstructured":"Peavy GM, Edland SD, Toole BM, Hansen LA, Galasko DR, Mayo AM (2016) Phenotypic differences based on staging of Alzheimer\u2019s neuropathology in autopsy-confirmed dementia with Lewy bodies. Parkinsonism Relat Disord 31:72\u201378","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR365","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1212\/WNL.0000000000003634","volume":"88","author":"KF Pedersen","year":"2017","unstructured":"Pedersen KF, Larsen JP, Tysnes OB, Alves G (2017) Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study. Neurology 88:767\u2013774","journal-title":"Neurology"},{"key":"1821_CR366","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/gps.4342","volume":"30","author":"LR Peraza","year":"2015","unstructured":"Peraza LR, Colloby SJ, Firbank MJ, Greasy GS, McKeith IG, Kaiser M, O\u2019Brien J, Taylor JP (2015) Resting state in Parkinson\u2019s disease dementia and dementia with Lewy bodies: commonalities and differences. Int J Geriatr Psychiatry 30:1135\u20131146","journal-title":"Int J Geriatr Psychiatry"},{"key":"1821_CR367","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1159\/000132084","volume":"25","author":"R Perneczky","year":"2008","unstructured":"Perneczky R, Drzezga A, Boecker H, Forstl H, Kurz A, Haussermann P (2008) Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations. Dement Geriatr Cogn Disord 25:531\u2013538","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1821_CR368","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.0b013e3182698d4a","volume":"79","author":"M Petrou","year":"2012","unstructured":"Petrou M, Bohnen NI, Muller ML, Koeppe RA, Albin RL, Frey KA (2012) Abeta-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology 79:1161\u20131167","journal-title":"Neurology"},{"key":"1821_CR369","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mds.26191","volume":"30","author":"M Petrou","year":"2015","unstructured":"Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, Muller ML, Albin RL, Frey KA (2015) Amyloid deposition in Parkinson\u2019s disease and cognitive impairment: a systematic review. Mov Disord 30:928\u2013935","journal-title":"Mov Disord"},{"key":"1821_CR370","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/acn3.231","volume":"2","author":"T Peuralinna","year":"2015","unstructured":"Peuralinna T, Myllykangas L, Oinas M, Nalls MA, Keage HA, Isoviita VM, Valori M, Polvikoski T, Paetau A, Sulkava R, Ince PG, Zaccai J, Brayne C, Traynor BJ, Hardy J, Singleton AB, Tienari PJ (2015) Genome-wide association study of neocortical Lewy-related pathology. Ann Clin Transl Neurol 2:920\u2013931","journal-title":"Ann Clin Transl Neurol"},{"key":"1821_CR371","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.bbrc.2016.09.114","volume":"479","author":"M Pietrzak","year":"2016","unstructured":"Pietrzak M, Papp A, Curtis A, Handelman SK, Kataki M, Scharre DW, Rempala G, Sadee W (2016) Gene expression profiling of brain samples from patients with Lewy body dementia. Biochem Biophys Res Commun 479:875\u2013880","journal-title":"Biochem Biophys Res Commun"},{"key":"1821_CR372","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.neurobiolaging.2004.10.006","volume":"26","author":"O Pletnikova","year":"2005","unstructured":"Pletnikova O, West N, Lee MK, Rudow GL, Skolasky RL, Dawson TM, Marsh L, Troncoso JC (2005) Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging 26:1183\u20131192","journal-title":"Neurobiol Aging"},{"key":"1821_CR373","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/bs.irn.2017.01.008","volume":"132","author":"RB Postuma","year":"2017","unstructured":"Postuma RB, Berg D (2017) The new diagnostic criteria for Parkinson\u2019s disease. Int Rev Neurobiol 132:55\u201378","journal-title":"Int Rev Neurobiol"},{"key":"1821_CR374","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"1821_CR375","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/2231-4040.191416","volume":"7","author":"KG Prakash","year":"2016","unstructured":"Prakash KG, Bannur BM, Chavan MD, Saniya K, Sailesh KS, Rajagopalan A (2016) Neuroanatomical changes in Parkinson\u2019s disease in relation to cognition: an update. J Adv Pharm Technol Res 7:123\u2013126","journal-title":"J Adv Pharm Technol Res"},{"key":"1821_CR376","first-page":"303","volume":"Suppl","author":"G Ransmayr","year":"2000","unstructured":"Ransmayr G (2000) Dementia with Lewy bodies: prevalence, clinical spectrum and natural history. J Neural Transm Suppl:303\u2013314","journal-title":"J Neural Transm"},{"issue":"Suppl 2","key":"1821_CR377","doi-asserted-by":"crossref","first-page":"S732","DOI":"10.1002\/mds.22499","volume":"24","author":"O Rascol","year":"2009","unstructured":"Rascol O, Schelosky L (2009) 123I-metaiodobenzylguanidine scintigraphy in Parkinson\u2019s disease and related disorders. Mov Disord 24(Suppl 2):S732\u2013S741","journal-title":"Mov Disord"},{"key":"1821_CR378","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000334765","volume":"10","author":"I Rektorova","year":"2012","unstructured":"Rektorova I, Krajcovicova L, Marecek R, Mikl M (2012) Default mode network and extrastriate visual resting state network in patients with Parkinson\u2019s disease dementia. Neurodegener Dis 10:232\u2013237","journal-title":"Neurodegener Dis"},{"key":"1821_CR379","doi-asserted-by":"crossref","first-page":"e85595","DOI":"10.1371\/journal.pone.0085595","volume":"9","author":"I Rektorova","year":"2014","unstructured":"Rektorova I, Biundo R, Marecek R, Weis L, Aarsland D, Antonini A (2014) Grey matter changes in cognitively impaired Parkinson\u2019s disease patients. PLoS One 9:e85595","journal-title":"PLoS One"},{"key":"1821_CR380","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/nan.12299","volume":"42","author":"NL Rey","year":"2016","unstructured":"Rey NL, George S, Brundin P (2016) Review: spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein. Neuropathol Appl Neurobiol 42:51\u201376","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1821_CR381","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/mds.10274","volume":"17","author":"IH Richard","year":"2002","unstructured":"Richard IH, Papka M, Rubio A, Kurlan R (2002) Parkinson\u2019s disease and dementia with Lewy bodies: one disease or two? Mov Disord 17:1161\u20131165","journal-title":"Mov Disord"},{"key":"1821_CR382","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","volume":"86","author":"G Rizzo","year":"2016","unstructured":"Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G (2016) Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 86:566\u2013576","journal-title":"Neurology"},{"key":"1821_CR383","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316844","author":"G Rizzo","year":"2017","unstructured":"Rizzo G, Arcuti S, Copetti M, Alessandria M, Savica R, Fontana A, Liguori R, Logroscino G (2017) Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2017-316844","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR384","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/brain\/awu057","volume":"137","author":"E Rockenstein","year":"2014","unstructured":"Rockenstein E, Nuber S, Overk CR, Ubhi K, Mante M, Patrick C, Adame A, Trejo-Morales M, Gerez J, Picotti P, Jensen PH, Campioni S, Riek R, Winkler J, Gage FH, Winner B, Masliah E (2014) Accumulation of oligomer-prone alpha-synuclein exacerbates synaptic and neuronal degeneration in vivo. Brain 137:1496\u20131513","journal-title":"Brain"},{"key":"1821_CR385","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/jnen\/nlw087","volume":"75","author":"Z Rohan","year":"2016","unstructured":"Rohan Z, Milenkovic I, Lutz MI, Matej R, Kovacs GG (2016) Shared and distinct patterns of oligodendroglial response in alpha-synucleinopathies and tauopathies. J Neuropathol Exp Neurol 75:1100\u20131109","journal-title":"J Neuropathol Exp Neurol"},{"key":"1821_CR386","first-page":"CD006504","volume":"3","author":"M Rolinski","year":"2012","unstructured":"Rolinski M, Fox C, Maidment I, McShane R (2012) Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson\u2019s disease dementia and cognitive impairment in Parkinson\u2019s disease. Cochrane Database Syst Rev 3:CD006504","journal-title":"Cochrane Database Syst Rev"},{"key":"1821_CR387","first-page":"469","volume-title":"Oxford textbook of old age psychiatry","author":"A Rongve","year":"2013","unstructured":"Rongve A, Aarsland D (2013) Dementia in Parkinson\u2019s disease and dementia with Lewy bodies. In: Dening T, Thomas A (eds) Oxford textbook of old age psychiatry, 2nd edn. Oxford University Press, Oxford, pp 469\u2013478","edition":"2"},{"key":"1821_CR388","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13195-016-0196-8","volume":"8","author":"D Roquet","year":"2016","unstructured":"Roquet D, Sourty M, Botzung A, Armspach JP, Blanc F (2016) Brain perfusion in dementia with Lewy bodies and Alzheimer\u2019s disease: an arterial spin labeling MRI study on prodromal and mild dementia stages. Alzheimers Res Ther 8:29","journal-title":"Alzheimers Res Ther"},{"key":"1821_CR389","doi-asserted-by":"crossref","first-page":"15573","DOI":"10.1073\/pnas.1405700111","volume":"111","author":"M Rothaug","year":"2014","unstructured":"Rothaug M, Zunke F, Mazzulli JR, Schweizer M, Altmeppen H, Lullmann-Rauch R, Kallemeijn WW, Gaspar P, Aerts JM, Glatzel M, Saftig P, Krainc D, Schwake M, Blanz J (2014) LIMP-2 expression is critical for beta-glucocerebrosidase activity and alpha-synuclein clearance. Proc Natl Acad Sci USA 111:15573\u201315578","journal-title":"Proc Natl Acad Sci USA"},{"key":"1821_CR390","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/nan.12294","volume":"42","author":"C Ruffmann","year":"2016","unstructured":"Ruffmann C, Calboli FC, Bravi I, Gveric D, Curry LK, de Smith A, Pavlou S, Buxton JL, Blakemore AI, Takousis P, Molloy S, Piccini P, Dexter DT, Roncaroli F, Gentleman SM, Middleton LT (2016) Cortical Lewy bodies and Abeta burden are associated with prevalence and timing of dementia in Lewy body diseases. Neuropathol Appl Neurobiol 42:436\u2013450","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1821_CR391","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3233\/JAD-161089","volume":"58","author":"D Sadiq","year":"2017","unstructured":"Sadiq D, Whitfield T, Lee L, Stevens T, Costafreda S, Walker Z (2017) Prodromal dementia with Lewy bodies and prodromal Alzheimer\u2019s disease: a comparison of the cognitive and clinical profiles. J Alzheimers Dis 58:463\u2013470","journal-title":"J Alzheimers Dis"},{"key":"1821_CR392","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40035-017-0076-6","volume":"6","author":"U Saeed","year":"2017","unstructured":"Saeed U, Compagnone J, Aviv RI, Strafella AP, Black SE, Lang AE, Masellis M (2017) Imaging biomarkers in Parkinson\u2019s disease and Parkinsonian syndromes: current and emerging concepts. Transl Neurodegener 6:8","journal-title":"Transl Neurodegener"},{"key":"1821_CR393","doi-asserted-by":"crossref","first-page":"20160156","DOI":"10.1259\/bjr.20160156","volume":"90","author":"F Sakamoto","year":"2017","unstructured":"Sakamoto F, Shiraishi S, Tsuda N, Hashimoto M, Tomiguchi S, Ikeda M, Yamashita Y (2017) Diagnosis of dementia with Lewy bodies: can 123I-IMP and 123I-MIBG scintigraphy yield new core features? Br J Radiol 90:20160156","journal-title":"Br J Radiol"},{"key":"1821_CR394","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/mds.22488","volume":"24","author":"C Sanchez-Castaneda","year":"2009","unstructured":"Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, Campdelacreu J, Gascon J, Falcon C, Calopa M, Jauma S, Juncadella M, Junque C (2009) Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson\u2019s disease with dementia. Mov Disord 24:1740\u20131746","journal-title":"Mov Disord"},{"key":"1821_CR395","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.parkreldis.2015.08.024","volume":"21","author":"G Santangelo","year":"2015","unstructured":"Santangelo G, Vitale C, Picillo M, Moccia M, Cuoco S, Longo K, Pezzella D, di Grazia A, Erro R, Pellecchia MT, Amboni M, Trojano L, Barone P (2015) Mild cognitive impairment in newly diagnosed Parkinson\u2019s disease: a longitudinal prospective study. Parkinsonism Relat Disord 21:1219\u20131226","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR396","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12511","author":"G Santpere","year":"2017","unstructured":"Santpere G, Garcia-Esparcia P, Andres-Benito P, Lorente-Galdos B, Navarro A, Ferrer I (2017) Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies. Brain Pathol. https:\/\/doi.org\/10.1111\/bpa.12511","journal-title":"Brain Pathol"},{"key":"1821_CR397","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1093\/brain\/aww193","volume":"139","author":"L Sarro","year":"2016","unstructured":"Sarro L, Senjem ML, Lundt ES, Przybelski SA, Lesnick TG, Graff-Radford J, Boeve BF, Lowe VJ, Ferman TJ, Knopman DS, Comi G, Filippi M, Petersen RC, Jack CR Jr, Kantarci K (2016) Amyloid-beta deposition and regional grey matter atrophy rates in dementia with Lewy bodies. Brain 139:2740\u20132750","journal-title":"Brain"},{"key":"1821_CR398","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2016.07.003","volume":"13","author":"L Sarro","year":"2017","unstructured":"Sarro L, Tosakulwong N, Schwarz CG, Graff-Radford J, Przybelski SA, Lesnick TG, Zuk SM, Reid RI, Raman MR, Boeve BF, Ferman TJ, Knopman DS, Comi G, Filippi M, Murray ME, Parisi JE, Dickson DW, Petersen RC, Jack CR Jr, Kantarci K (2017) An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer\u2019s disease. Alzheimers Dement 13:257\u2013266","journal-title":"Alzheimers Dement"},{"key":"1821_CR399","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1001\/jamaneurol.2013.3579","volume":"70","author":"R Savica","year":"2013","unstructured":"Savica R, Grossardt BR, Bower JH, Boeve BF, Ahlskog JE, Rocca WA (2013) Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol 70:1396\u20131402","journal-title":"JAMA Neurol"},{"key":"1821_CR400","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/jamaneurol.2017.0603","volume":"74","author":"R Savica","year":"2017","unstructured":"Savica R, Grossardt BR, Bower JH, Ahlskog JE, Boeve BF, Graff-Radford J, Rocca WA, Mielke MM (2017) Survival and causes of death among people with clinically diagnosed synucleinopathies with parkinsonism: a population-based study. JAMA Neurol 74:839\u2013846","journal-title":"JAMA Neurol"},{"key":"1821_CR401","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.26878","volume":"32","author":"DB Schenk","year":"2017","unstructured":"Schenk DB, Koller M, Ness DK, Griffith SG, Grundman M, Zago W, Soto J, Atiee G, Ostrowitzki S, Kinney GG (2017) First-in-human assessment of PRX002, an anti-alpha-synuclein monoclonal antibody, in healthy volunteers. Mov Disord 32:211\u2013218","journal-title":"Mov Disord"},{"key":"1821_CR402","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/mds.26377","volume":"31","author":"A Schneeberger","year":"2016","unstructured":"Schneeberger A, Tierney L, Mandler M (2016) Active immunization therapies for Parkinson\u2019s disease and multiple system atrophy. Mov Disord 31:214\u2013224","journal-title":"Mov Disord"},{"key":"1821_CR403","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/mds.27193","volume":"32","author":"SA Schneider","year":"2017","unstructured":"Schneider SA, Alcalay RN (2017) Neuropathology of genetic synucleinopathies with Parkinsonism: review of the literature. Mov Disord 32:1504\u20131523","journal-title":"Mov Disord"},{"key":"1821_CR404","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/brain\/aws234","volume":"135","author":"JA Schneider","year":"2012","unstructured":"Schneider JA, Arvanitakis Z, Yu L, Boyle PA, Leurgans SE, Bennett DA (2012) Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain 135:3005\u20133014","journal-title":"Brain"},{"key":"1821_CR405","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","volume":"16","author":"A Schrag","year":"2017","unstructured":"Schrag A, Siddiqui UF, Anastasiou Z, Weintraub D, Schott JM (2017) Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson\u2019s disease: a cohort study. Lancet Neurol 16:66\u201375","journal-title":"Lancet Neurol"},{"key":"1821_CR406","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","volume":"120","author":"WJ Schulz-Schaeffer","year":"2010","unstructured":"Schulz-Schaeffer WJ (2010) The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia. Acta Neuropathol 120:131\u2013143","journal-title":"Acta Neuropathol"},{"key":"1821_CR407","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1523\/JNEUROSCI.1091-10.2010","volume":"30","author":"DA Scott","year":"2010","unstructured":"Scott DA, Tabarean I, Tang Y, Cartier A, Masliah E, Roy S (2010) A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration. J Neurosci 30:8083\u20138095","journal-title":"J Neurosci"},{"key":"1821_CR408","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neubiorev.2016.08.003","volume":"71","author":"C Seer","year":"2016","unstructured":"Seer C, Lange F, Georgiev D, Jahanshahi M, Kopp B (2016) Event-related potentials and cognition in Parkinson\u2019s disease: an integrative review. Neurosci Biobehav Rev 71:691\u2013714","journal-title":"Neurosci Biobehav Rev"},{"key":"1821_CR409","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1148\/radiol.12111280","volume":"263","author":"TM Seibert","year":"2012","unstructured":"Seibert TM, Murphy EA, Kaestner EJ, Brewer JB (2012) Interregional correlations in Parkinson disease and Parkinson-related dementia with resting functional MR imaging. Radiology 263:226\u2013234","journal-title":"Radiology"},{"key":"1821_CR410","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/bpa.12168","volume":"25","author":"K Seidel","year":"2015","unstructured":"Seidel K, Mahlke J, Siswanto S, Kruger R, Heinsen H, Auburger G, Bouzrou M, Grinberg LT, Wicht H, Korf HW, den Dunnen W, Rub U (2015) The brainstem pathologies of Parkinson\u2019s disease and dementia with Lewy bodies. Brain Pathol 25:121\u2013135","journal-title":"Brain Pathol"},{"key":"1821_CR411","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/brain\/awp234","volume":"132","author":"M Selikhova","year":"2009","unstructured":"Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson\u2019s disease. Brain 132:2947\u20132957","journal-title":"Brain"},{"issue":"Suppl. 3","key":"1821_CR412","first-page":"A127","volume":"56","author":"K Seppi","year":"2001","unstructured":"Seppi K, Jellinger K, Litvan I, Ransmayr G, Mueller J, Ulmer H, Poewe W, Wenning GK (2001) Impact of disease progression upon accuracy of the McKeith criteria for dementia with Lewy bodies: a clinicopathologic study (abstr). Neurology 56(Suppl. 3):A127","journal-title":"Neurology"},{"key":"1821_CR413","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archneurol.2011.17","volume":"68","author":"N Seto-Salvia","year":"2011","unstructured":"Seto-Salvia N, Clarimon J, Pagonabarraga J, Pascual-Sedano B, Campolongo A, Combarros O, Mateo JI, Regana D, Martinez-Corral M, Marquie M, Alcolea D, Suarez-Calvet M, Molina-Porcel L, Dols O, Gomez-Isla T, Blesa R, Lleo A, Kulisevsky J (2011) Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes. Arch Neurol 68:359\u2013364","journal-title":"Arch Neurol"},{"key":"1821_CR414","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/mds.24045","volume":"27","author":"N Seto-Salvia","year":"2012","unstructured":"Seto-Salvia N, Pagonabarraga J, Houlden H, Pascual-Sedano B, Dols-Icardo O, Tucci A, Paisan-Ruiz C, Campolongo A, Anton-Aguirre S, Martin I, Munoz L, Bufill E, Vilageliu L, Grinberg D, Cozar M, Blesa R, Lleo A, Hardy J, Kulisevsky J, Clarimon J (2012) Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson\u2019s disease course. Mov Disord 27:393\u2013399","journal-title":"Mov Disord"},{"key":"1821_CR415","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2011.06.047","volume":"310","author":"Y Sharabi","year":"2011","unstructured":"Sharabi Y, Goldstein DS (2011) Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease. J Neurol Sci 310:123\u2013128","journal-title":"J Neurol Sci"},{"key":"1821_CR416","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000161058","volume":"26","author":"SI Sharp","year":"2008","unstructured":"Sharp SI, Ballard CG, Ziabreva I, Piggott MA, Perry RH, Perry EK, Aarsland D, Ehrt U, Larsen JP, Francis PT (2008) Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson\u2019s disease dementia. Dement Geriatr Cogn Disord 26:330\u2013338","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1821_CR417","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","volume":"73","author":"H Shimada","year":"2009","unstructured":"Shimada H, Hirano S, Shinotoh H, Aotsuka A, Sato K, Tanaka N, Ota T, Asahina M, Fukushi K, Kuwabara S, Hattori T, Suhara T, Irie T (2009) Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 73:273\u2013278","journal-title":"Neurology"},{"key":"1821_CR418","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12149-017-1166-3","volume":"31","author":"S Shimizu","year":"2017","unstructured":"Shimizu S, Hirose D, Namioka N, Kanetaka H, Hirao K, Hatanaka H, Takenoshita N, Kaneko Y, Ogawa Y, Umahara T, Sakurai H, Hanyu H (2017) Correlation between clinical symptoms and striatal DAT uptake in patients with DLB. Ann Nucl Med 31:390\u2013398","journal-title":"Ann Nucl Med"},{"key":"1821_CR419","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jamaneurol.2016.1593","volume":"73","author":"T Shiner","year":"2016","unstructured":"Shiner T, Mirelman A, Gana Weisz M, Bar-Shira A, Ash E, Cialic R, Nevler N, Gurevich T, Bregman N, Orr-Urtreger A, Giladi N (2016) High frequency of GBA gene mutations in dementia with Lewy bodies among Ashkenazi jews. JAMA Neurol 73:1448\u20131453","journal-title":"JAMA Neurol"},{"key":"1821_CR420","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","volume":"75","author":"A Siderowf","year":"2010","unstructured":"Siderowf A, Xie SX, Hurtig H, Weintraub D, Duda J, Chen-Plotkin A, Shaw LM, Van Deerlin V, Trojanowski JQ, Clark C (2010) CSF amyloid beta 1\u201342 predicts cognitive decline in Parkinson disease. Neurology 75:1055\u20131061","journal-title":"Neurology"},{"key":"1821_CR421","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen CM, Clark LN, Condroyer C, De Marco EV, Durr A, Eblan MJ, Fahn S, Farrer MJ, Fung HC, Gan-Or Z, Gasser T, Gershoni-Baruch R, Giladi N, Griffith A, Gurevich T, Januario C, Kropp P, Lang AE, Lee-Chen GJ, Lesage S, Marder K, Mata IF, Mirelman A, Mitsui J, Mizuta I, Nicoletti G, Oliveira C, Ottman R, Orr-Urtreger A, Pereira LV, Quattrone A, Rogaeva E, Rolfs A, Rosenbaum H, Rozenberg R, Samii A, Samaddar T, Schulte C, Sharma M, Singleton A, Spitz M, Tan EK, Tayebi N, Toda T, Troiano AR, Tsuji S, Wittstock M, Wolfsberg TG, Wu YR, Zabetian CP, Zhao Y, Ziegler SG (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med 361:1651\u20131661","journal-title":"N Engl J Med"},{"key":"1821_CR422","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/mds.26327","volume":"31","author":"FJ Siepel","year":"2016","unstructured":"Siepel FJ, Dalen I, Gruner R, Booij J, Bronnick KS, Buter TC, Aarsland D (2016) Loss of dopamine transporter binding and clinical symptoms in dementia with Lewy bodies. Mov Disord 31:118\u2013125","journal-title":"Mov Disord"},{"key":"1821_CR423","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/nan.12308","volume":"42","author":"M Sierra","year":"2016","unstructured":"Sierra M, Gelpi E, Marti MJ, Compta Y (2016) Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum. Neuropathol Appl Neurobiol 42:451\u2013462","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1821_CR424","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Kruger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M, Nalls MA, Illig T, Gieger C, Houlden H, Steffens M, Okun MS, Racette BA, Cookson MR, Foote KD, Fernandez HH, Traynor BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M, Lopez G, Chanock SJ, Schatzkin A, Park Y, Hollenbeck A, Gao J, Huang X, Wood NW, Lorenz D, Deuschl G, Chen H, Riess O, Hardy JA, Singleton AB, Gasser T (2009) Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet 41:1308\u20131312","journal-title":"Nat Genet"},{"key":"1821_CR425","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2217\/BMM.14.105","volume":"10","author":"AH Simonsen","year":"2016","unstructured":"Simonsen AH, Kuiperij B, El-Agnaf OM, Engelborghs S, Herukka SK, Parnetti L, Rektorova I, Vanmechelen E, Kapaki E, Verbeek M, Mollenhauer B (2016) The utility of alpha-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature. Biomark Med 10:19\u201334","journal-title":"Biomark Med"},{"key":"1821_CR426","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3233\/JPD-150682","volume":"5","author":"RE Skogseth","year":"2015","unstructured":"Skogseth RE, Bronnick K, Pereira JB, Mollenhauer B, Weintraub D, Fladby T, Aarsland D (2015) Associations between cerebrospinal fluid biomarkers and cognition in early untreated Parkinson\u2019s disease. J Parkinsons Dis 5:783\u2013792","journal-title":"J Parkinsons Dis"},{"key":"1821_CR427","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3233\/JAD-170274","volume":"59","author":"RE Skogseth","year":"2017","unstructured":"Skogseth RE, Hortobagyi T, Soennesyn H, Chwiszczuk L, Ffytche D, Rongve A, Ballard C, Aarsland D (2017) Accuracy of clinical diagnosis of dementia with Lewy bodies versus neuropathology. J Alzheimers Dis 59:1139\u20131152","journal-title":"J Alzheimers Dis"},{"key":"1821_CR428","first-page":"276","volume":"41","author":"T Sobow","year":"2007","unstructured":"Sobow T (2007) Parkinson\u2019s disease-related visual hallucinations unresponsive to atypical antipsychotics treated with cholinesterase inhibitors: a case series. Neurol Neurochir Pol 41:276\u2013279","journal-title":"Neurol Neurochir Pol"},{"key":"1821_CR429","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2011.07.047","volume":"310","author":"JH Somme","year":"2011","unstructured":"Somme JH, Gomez-Esteban JC, Molano A, Tijero B, Lezcano E, Zarranz JJ (2011) Initial neuropsychological impairments in patients with the E46K mutation of the alpha-synuclein gene (PARK 1). J Neurol Sci 310:86\u201389","journal-title":"J Neurol Sci"},{"key":"1821_CR430","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ana.21208","volume":"62","author":"JA Sonnen","year":"2007","unstructured":"Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, Craft S, Leverenz JB, Montine TJ (2007) Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 62:406\u2013413","journal-title":"Ann Neurol"},{"key":"1821_CR431","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40478-016-0410-8","volume":"5","author":"B Spencer","year":"2017","unstructured":"Spencer B, Valera E, Rockenstein E, Overk C, Mante M, Adame A, Zago W, Seubert P, Barbour R, Schenk D, Games D, Rissman RA, Masliah E (2017) Anti-alpha-synuclein immunotherapy reduces alpha-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy. Acta Neuropathol Commun 5:7","journal-title":"Acta Neuropathol Commun"},{"key":"1821_CR432","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones TL, Attems J, Thal DR (2017) Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol 134:187\u2013205","journal-title":"Acta Neuropathol"},{"key":"1821_CR433","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.parkreldis.2015.04.027","volume":"21","author":"AL Stav","year":"2015","unstructured":"Stav AL, Aarsland D, Johansen KK, Hessen E, Auning E, Fladby T (2015) Amyloid-beta and alpha-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson\u2019s disease. Parkinsonism Relat Disord 21:758\u2013764","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR434","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1176\/appi.ajp.2015.14121582","volume":"172","author":"C Stinton","year":"2015","unstructured":"Stinton C, McKeith I, Taylor JP, Lafortune L, Mioshi E, Mak E, Cambridge V, Mason J, Thomas A, O\u2019Brien JT (2015) Pharmacological management of Lewy body dementia: a systematic review and meta-analysis. Am J Psychiatry 172:731\u2013742","journal-title":"Am J Psychiatry"},{"key":"1821_CR435","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mds.26907","volume":"32","author":"AP Strafella","year":"2017","unstructured":"Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, Pineda-Pardo JA, Cilia R, Ballanger B, Niethammer M, Stoessl JA (2017) Molecular imaging to track Parkinson\u2019s disease and atypical parkinsonisms: new imaging frontiers. Mov Disord 32:181\u2013192","journal-title":"Mov Disord"},{"key":"1821_CR436","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","volume":"60","author":"D Strozyk","year":"2003","unstructured":"Strozyk D, Blennow K, White LR, Launer LJ (2003) CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60:652\u2013656","journal-title":"Neurology"},{"key":"1821_CR437","doi-asserted-by":"crossref","first-page":"e005158","DOI":"10.1136\/bmjopen-2014-005158","volume":"4","author":"K Stubendorff","year":"2014","unstructured":"Stubendorff K, Larsson V, Ballard C, Minthon L, Aarsland D, Londos E (2014) Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson\u2019s disease with dementia: a prospective study. BMJ Open 4:e005158","journal-title":"BMJ Open"},{"key":"1821_CR438","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/brain\/awv346","volume":"139","author":"A Stuendl","year":"2016","unstructured":"Stuendl A, Kunadt M, Kruse N, Bartels C, Moebius W, Danzer KM, Mollenhauer B, Schneider A (2016) Induction of alpha-synuclein aggregate formation by CSF exosomes from patients with Parkinson\u2019s disease and dementia with Lewy bodies. Brain 139:481\u2013494","journal-title":"Brain"},{"key":"1821_CR439","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jns.2005.08.011","volume":"240","author":"M Suzuki","year":"2006","unstructured":"Suzuki M, Kurita A, Hashimoto M, Fukumitsu N, Abo M, Ito Y, Urashima M, Inoue K (2006) Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson\u2019s disease. J Neurol Sci 240:15\u201319","journal-title":"J Neurol Sci"},{"key":"1821_CR440","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","volume":"11","author":"P Svenningsson","year":"2012","unstructured":"Svenningsson P, Westman E, Ballard C, Aarsland D (2012) Cognitive impairment in patients with Parkinson\u2019s disease: diagnosis, biomarkers, and treatment. Lancet Neurol 11:697\u2013707","journal-title":"Lancet Neurol"},{"key":"1821_CR441","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13195-014-0077-y","volume":"6","author":"M Swirski","year":"2014","unstructured":"Swirski M, Miners JS, de Silva R, Lashley T, Ling H, Holton J, Revesz T, Love S (2014) Evaluating the relationship between amyloid-\u03b2 and a-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson\u2019s disease. Alzheimers Res Ther 6:77","journal-title":"Alzheimers Res Ther"},{"key":"1821_CR442","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/0891988717711451","volume":"30","author":"JYY Szeto","year":"2017","unstructured":"Szeto JYY, Halliday GM, Naismith SL, Lewis SJG (2017) Exploring the phenotype in mild cognitive impairment to aid the prediction of those at risk of transitioning to Parkinson disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 30:196\u2013205","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"1821_CR443","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/JAD-150952","volume":"52","author":"M Takemoto","year":"2016","unstructured":"Takemoto M, Sato K, Hatanaka N, Yamashita T, Ohta Y, Hishikawa N, Abe K (2016) Different clinical and neuroimaging characteristics in early stage Parkinson\u2019s disease with dementia and dementia with Lewy bodies. J Alzheimers Dis 52:205\u2013211","journal-title":"J Alzheimers Dis"},{"key":"1821_CR444","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1212\/01.WNL.0000153070.82309.D4","volume":"64","author":"CW Tam","year":"2005","unstructured":"Tam CW, Burton EJ, McKeith IG, Burn DJ, O\u2019Brien JT (2005) Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 64:861\u2013865","journal-title":"Neurology"},{"key":"1821_CR445","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.nbd.2011.05.022","volume":"43","author":"K Tanji","year":"2011","unstructured":"Tanji K, Mori F, Kakita A, Takahashi H, Wakabayashi K (2011) Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease. Neurobiol Dis 43:690\u2013697","journal-title":"Neurobiol Dis"},{"key":"1821_CR446","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mds.25814","volume":"29","author":"CM Tanner","year":"2014","unstructured":"Tanner CM, Meng CC, Ravina B, Lang A, Kurlan R, Marek K, Oakes D, Seibyl J, Flagg E, Gauger L, Guest DD, Goetz CG, Kieburtz K, DiEuliis D, Fahn S, Elliott RA, Shoulson I (2014) A practical approach to remote longitudinal follow-up of Parkinson\u2019s disease: the FOUND study. Mov Disord 29:743\u2013749","journal-title":"Mov Disord"},{"key":"1821_CR447","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/acn3.389","volume":"4","author":"M Tanskanen","year":"2017","unstructured":"Tanskanen M, Makela M, Notkola IL, Myllykangas L, Rastas S, Oinas M, Lindsberg PJ, Polvikoski T, Tienari PJ, Paetau A (2017) Population-based analysis of pathological correlates of dementia in the oldest old. Ann Clin Transl Neurol 4:154\u2013165","journal-title":"Ann Clin Transl Neurol"},{"key":"1821_CR448","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12031-015-0647-x","volume":"58","author":"M Terrelonge Jr","year":"2016","unstructured":"Terrelonge M Jr, Marder KS, Weintraub D, Alcalay RN (2016) CSF beta-amyloid 1\u201342 predicts progression to cognitive impairment in newly diagnosed parkinson disease. J Mol Neurosci 58:88\u201392","journal-title":"J Mol Neurosci"},{"key":"1821_CR449","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0000000000003512","volume":"88","author":"AJ Thomas","year":"2017","unstructured":"Thomas AJ, Attems J, Colloby SJ, O\u2019Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z (2017a) Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology 88:276\u2013283","journal-title":"Neurology"},{"key":"1821_CR450","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1212\/WNL.0000000000004254","volume":"89","author":"AJ Thomas","year":"2017","unstructured":"Thomas AJ, Attems J, Colloby SJ, O\u2019Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z (2017b) 2017a-Author response: autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. Neurology 89:751","journal-title":"Neurology"},{"key":"1821_CR451","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0000000000001204","volume":"84","author":"P Tiraboschi","year":"2015","unstructured":"Tiraboschi P, Attems J, Thomas A, Brown A, Jaros E, Lett DJ, Ossola M, Perry RH, Ramsay L, Walker L, McKeith IG (2015) Clinicians\u2019 ability to diagnose dementia with Lewy bodies is not affected by beta-amyloid load. Neurology 84:496\u2013499","journal-title":"Neurology"},{"key":"1821_CR452","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ana.24717","volume":"80","author":"P Tiraboschi","year":"2016","unstructured":"Tiraboschi P, Corso A, Guerra UP, Nobili F, Piccardo A, Calcagni ML, Volterrani D, Cecchin D, Tettamanti M, Antelmi L, Vidale S, Sacco L, Merello M, Stefanini S, Micheli A, Vai P, Capitanio S, Gabanelli SV, Riva R, Pinto P, Biffi AM, Muscio C (2016) (123) I-2beta-carbomethoxy-3beta-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with Lewy bodies from other dementias: a comparative study. Ann Neurol 80:368\u2013378","journal-title":"Ann Neurol"},{"key":"1821_CR453","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","volume":"131","author":"JB Toledo","year":"2016","unstructured":"Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S, Waits K, Boluda S, Grossman M, Van Deerlin VM, Lee EB, Arnold SE, Duda JE, Hurtig H, Lee VM, Adler CH, Beach TG, Trojanowski JQ (2016) Pathological alpha-synuclein distribution in subjects with coincident Alzheimer\u2019s and Lewy body pathology. Acta Neuropathol 131:393\u2013409","journal-title":"Acta Neuropathol"},{"key":"1821_CR454","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-10017-13155-10077","author":"L Trojano","year":"2017","unstructured":"Trojano L, Papagno C (2017) Cognitive and behavioral disorders in Parkinson\u2019s disease: an update. II: behavioral disorders. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-10017-13155-10077","journal-title":"Neurol Sci"},{"issue":"Suppl 2","key":"1821_CR455","first-page":"S377","volume":"32","author":"T Tropea","year":"2017","unstructured":"Tropea T, Berlyand J, McBride J, Doshi J, Davatzikos C, Shaw L, Xie S, Trojanowski J, Weintraub D, Chen-Plotkin A (2017a) Multimodal biomarkers as predictors of cognitive decline in Parkinson\u2019s disease. Mov Disord 32(Suppl 2):S377","journal-title":"Mov Disord"},{"key":"1821_CR456","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27204","author":"TF Tropea","year":"2017","unstructured":"Tropea TF, Xie SX, Rick J, Chahine LM, Dahodwala N, Doshi J, Davatzikos C, Shaw LM, Van Deerlin V, Trojanowski JQ, Weintraub D, Chen-Plotkin AS (2017b) APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease. Mov Disord. https:\/\/doi.org.10.1002\/mds.27204","journal-title":"Mov Disord"},{"key":"1821_CR457","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","volume":"70","author":"D Tsuang","year":"2013","unstructured":"Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, Irwin DJ, Rick J, Schellenberg GD, Watson GS, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Quinn JF, Chung KA, Yearout D, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP (2013) APOE epsilon4 increases risk for dementia in pure synucleinopathies. JAMA Neurol 70:223\u2013228","journal-title":"JAMA Neurol"},{"issue":"Suppl 1","key":"1821_CR458","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.parkreldis.2004.10.014","volume":"11","author":"Y Tsuboi","year":"2005","unstructured":"Tsuboi Y, Dickson DW (2005) Dementia with Lewy bodies and Parkinson\u2019s disease with dementia: are they different? Parkinsonism Relat Disord 11(Suppl 1):S47\u2013S51","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 3","key":"1821_CR459","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1016\/S1353-8020(08)70005-1","volume":"13","author":"Y Tsuboi","year":"2007","unstructured":"Tsuboi Y, Uchikado H, Dickson DW (2007) Neuropathology of Parkinson\u2019s disease dementia and dementia with Lewy bodies with reference to striatal pathology. Parkinsonism Relat Disord 13(Suppl 3):S221\u2013S224","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR460","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4172\/2161-0460.1000214","volume":"6","author":"N Tsuno","year":"2016","unstructured":"Tsuno N (2016) The potential role of donepezil for the treatment of dementia with Lewy bodies. J Alzheimers Dis Parkinsonism 6:214","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"1821_CR461","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neulet.2010.09.016","volume":"485","author":"K Ubhi","year":"2010","unstructured":"Ubhi K, Peng K, Lessig S, Estrella J, Adame A, Galasko D, Salmon DP, Hansen LA, Kawas CH, Masliah E (2010) Neuropathology of dementia with Lewy bodies in advanced age: a comparison with Alzheimer disease. Neurosci Lett 485:222\u2013227","journal-title":"Neurosci Lett"},{"key":"1821_CR462","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/neup.12348","volume":"37","author":"T Uchihara","year":"2017","unstructured":"Uchihara T (2017) An order in Lewy body disorders: retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal\/multifocal Lewy body disease. Neuropathology 37:129\u2013149","journal-title":"Neuropathology"},{"key":"1821_CR463","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mds.26428","volume":"31","author":"E Valera","year":"2016","unstructured":"Valera E, Masliah E (2016) Combination therapies: the next logical Step for the treatment of synucleinopathies? Mov Disord 31:225\u2013234","journal-title":"Mov Disord"},{"key":"1821_CR464","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s00259-016-3312-x","volume":"43","author":"JJ Zande van der","year":"2016","unstructured":"van der Zande JJ, Booij J, Scheltens P, Raijmakers PG, Lemstra AW (2016) [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies. Eur J Nucl Med Mol Imaging 43:1060\u20131066","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1821_CR465","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/JAD-160322","volume":"54","author":"I Steenoven van","year":"2016","unstructured":"van Steenoven I, Aarsland D, Weintraub D, Londos E, Blanc F, van der Flier WM, Teunissen CE, Mollenhauer B, Fladby T, Kramberger MG, Bonanni L, Lemstra AW (2016) Cerebrospinal fluid Alzheimer\u2019s disease biomarkers across the spectrum of Lewy body diseases: results from a large multicenter cohort. J Alzheimers Dis 54:287\u2013295","journal-title":"J Alzheimers Dis"},{"key":"1821_CR466","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","volume":"44","author":"SA Vann Jones","year":"2014","unstructured":"Vann Jones SA, O\u2019Brien JT (2014) The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med 44:673\u2013683","journal-title":"Psychol Med"},{"key":"1821_CR467","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00415-010-5453-3","volume":"257","author":"S Varanese","year":"2010","unstructured":"Varanese S, Perfetti B, Monaco D, Thomas A, Bonanni L, Tiraboschi P, Onofrj M (2010) Fluctuating cognition and different cognitive and behavioural profiles in Parkinson\u2019s disease with dementia: comparison of dementia with Lewy bodies and Alzheimer\u2019s disease. J Neurol 257:1004\u20131011","journal-title":"J Neurol"},{"key":"1821_CR468","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.07.009","volume":"43","author":"LJM Vergouw","year":"2017","unstructured":"Vergouw LJM, van Steenoven I, van de Berg WDJ, Teunissen CE, van Swieten JC, Bonifati V, Lemstra AW, de Jong FJ (2017) An update on the genetics of dementia with Lewy bodies. Parkinsonism Relat Disord 43:1\u20138","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR469","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archneurol.2011.142","volume":"68","author":"VL Villemagne","year":"2011","unstructured":"Villemagne VL, Okamura N, Pejoska S, Drago J, Mulligan RS, Chetelat G, Ackermann U, O\u2019Keefe G, Jones G, Gong S, Tochon-Danguy H, Kung HF, Masters CL, Skovronsky DM, Rowe CC (2011) In vivo assessment of vesicular monoamine transporter type 2 in dementia with Lewy bodies and Alzheimer disease. Arch Neurol 68:905\u2013912","journal-title":"Arch Neurol"},{"key":"1821_CR470","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jns.2014.05.052","volume":"343","author":"HP Vranova","year":"2014","unstructured":"Vranova HP, Henykova E, Kaiserova M, Mensikova K, Vastik M, Mares J, Hlustik P, Zapletalova J, Strnad M, Stejskal D, Kanovsky P (2014) Tau protein, beta-amyloid 1\u201342 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia. J Neurol Sci 343:120\u2013124","journal-title":"J Neurol Sci"},{"key":"1821_CR471","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-neuro-071714-033828","volume":"38","author":"LC Walker","year":"2015","unstructured":"Walker LC, Jucker M (2015) Neurodegenerative diseases: expanding the prion concept. Annu Rev Neurosci 38:87\u2013103","journal-title":"Annu Rev Neurosci"},{"key":"1821_CR472","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/01.WNL.0000123248.39847.1D","volume":"62","author":"Z Walker","year":"2004","unstructured":"Walker Z, Costa DC, Walker RW, Lee L, Livingston G, Jaros E, Perry R, McKeith I, Katona CL (2004) Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology 62:1568\u20131572","journal-title":"Neurology"},{"key":"1821_CR473","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/jnnp.2006.110122","volume":"78","author":"Z Walker","year":"2007","unstructured":"Walker Z, Jaros E, Walker RW, Lee L, Costa DC, Livingston G, Ince PG, Perry R, McKeith I, Katona CL (2007) Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry 78:1176\u20131181","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR474","doi-asserted-by":"crossref","first-page":"e000380","DOI":"10.1136\/bmjopen-2011-000380","volume":"2","author":"Z Walker","year":"2012","unstructured":"Walker Z, McKeith I, Rodda J, Qassem T, Tatsch K, Booij J, Darcourt J, O\u2019Brien J (2012) Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer\u2019s disease: a cohort study. BMJ Open 2:e000380","journal-title":"BMJ Open"},{"key":"1821_CR475","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","volume":"129","author":"L Walker","year":"2015","unstructured":"Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J (2015a) Neuropathologically mixed Alzheimer\u2019s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol 129:729\u2013748","journal-title":"Acta Neuropathol"},{"key":"1821_CR476","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","volume":"386","author":"Z Walker","year":"2015","unstructured":"Walker Z, Possin KL, Boeve BF, Aarsland D (2015b) Lewy body dementias. Lancet 386:1683\u20131697","journal-title":"Lancet"},{"key":"1821_CR477","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1212\/WNL.0000000000003076","volume":"87","author":"Z Walker","year":"2016","unstructured":"Walker Z, Moreno E, Thomas A, Inglis F, Tabet N, Stevens T, Whitfield T, Aarsland D, Rainer M, Padovani A (2016) Evolution of clinical features in possible DLB depending on FP-CIT SPECT result. Neurology 87:1045\u20131051","journal-title":"Neurology"},{"key":"1821_CR478","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00415-005-0023-9","volume":"253","author":"U Walter","year":"2006","unstructured":"Walter U, Dressler D, Wolters A, Wittstock M, Greim B, Benecke R (2006) Sonographic discrimination of dementia with Lewy bodies and Parkinson\u2019s disease with dementia. J Neurol 253:448\u2013454","journal-title":"J Neurol"},{"key":"1821_CR479","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1212\/NXG.0000000000000085","volume":"2","author":"RL Walton","year":"2016","unstructured":"Walton RL, Soto-Ortolaza AI, Murray ME, Lorenzo-Betancor O, Ogaki K, Heckman MG, Rayaprolu S, Rademakers R, Ertekin-Taner N, Uitti RJ, van Gerpen JA, Wszolek ZK, Smith GE, Kantarci K, Lowe VJ, Parisi JE, Jones DT, Savica R, Graff-Radford J, Knopman DS, Petersen RC, Graff-Radford NR, Ferman TJ, Dickson DW, Boeve BF, Ross OA, Labbe C (2016) TREM2 p.R47H substitution is not associated with dementia with Lewy bodies. Neurol Genet 2:e85","journal-title":"Neurol Genet"},{"key":"1821_CR480","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jnnp-2014-307659","volume":"86","author":"HF Wang","year":"2015","unstructured":"Wang HF, Yu JT, Tang SW, Jiang T, Tan CC, Meng XF, Wang C, Tan MS, Tan L (2015) Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson\u2019s disease, Parkinson\u2019s disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis. J Neurol Neurosurg Psychiatry 86:135\u2013143","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR481","first-page":"39","volume":"56","author":"L Warr","year":"2012","unstructured":"Warr L, Walker Z (2012) Identification of biomarkers in Lewy-body disorders. Q J Nucl Med Mol Imaging 56:39\u201354","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1821_CR482","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1016\/j.bmc.2017.10.010","volume":"25","author":"H Watanabe","year":"2017","unstructured":"Watanabe H, Ariyoshi T, Ozaki A, Ihara M, Ono M, Saji H (2017) Synthesis and biological evaluation of novel radioiodinated benzimidazole derivatives for imaging alpha-synuclein aggregates. Bioorg Med Chem 25:6398\u20136403","journal-title":"Bioorg Med Chem"},{"key":"1821_CR483","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000264614","volume":"28","author":"R Watson","year":"2009","unstructured":"Watson R, Blamire AM, O\u2019Brien JT (2009) Magnetic resonance imaging in Lewy body dementias. Dement Geriatr Cogn Disord 28:493\u2013506","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1821_CR484","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1017\/S1041610211002171","volume":"24","author":"R Watson","year":"2012","unstructured":"Watson R, O\u2019Brien JT, Barber R, Blamire AM (2012) Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study. Int Psychogeriatr 24:532\u2013540","journal-title":"Int Psychogeriatr"},{"key":"1821_CR485","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2017.1010.1006","author":"R Watson","year":"2017","unstructured":"Watson R, Colloby SJ, Blamire AM, Wesnes KA, Wood J, O\u2019Brien JT (2017) Does attentional dysfunction and thalamic atrophy predict decline in dementia with Lewy bodies? Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.1010.1006","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR486","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.12688\/f1000research.11725.1","volume":"6","author":"RS Weil","year":"2017","unstructured":"Weil RS, Lashley TL, Bras J, Schrag AE, Schott JM (2017) Current concepts and controversies in the pathogenesis of Parkinson\u2019s disease dementia and Dementia with Lewy bodies. F1000Res 6:1604","journal-title":"F1000Res"},{"key":"1821_CR487","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1212\/01.wnl.0000266626.64913.0f","volume":"69","author":"D Weisman","year":"2007","unstructured":"Weisman D, Cho M, Taylor C, Adame A, Thal LJ, Hansen LA (2007) In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology 69:356\u2013359","journal-title":"Neurology"},{"key":"1821_CR488","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.0000000000002423","volume":"86","author":"H Wellington","year":"2016","unstructured":"Wellington H, Paterson RW, Portelius E, Tornqvist U, Magdalinou N, Fox NC, Blennow K, Schott JM, Zetterberg H (2016) Increased CSF neurogranin concentration is specific to Alzheimer disease. Neurology 86:829\u2013835","journal-title":"Neurology"},{"key":"1821_CR489","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13195-015-0145-y","volume":"7","author":"M Wennstrom","year":"2015","unstructured":"Wennstrom M, Hall S, Nagga K, Londos E, Minthon L, Hansson O (2015) Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients. Alzheimers Res Ther 7:63","journal-title":"Alzheimers Res Ther"},{"key":"1821_CR490","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2967\/jnumed.116.179903","volume":"58","author":"JL Whitwell","year":"2017","unstructured":"Whitwell JL, Graff-Radford J, Singh TD, Drubach DA, Senjem ML, Spychalla AJ, Tosakulwong N, Lowe VJ, Josephs KA (2017) 18F-FDG PET in posterior cortical atrophy and dementia with Lewy bodies. J Nucl Med 58:632\u2013638","journal-title":"J Nucl Med"},{"key":"1821_CR491","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jnnp-2011-301413","volume":"83","author":"C Wider","year":"2012","unstructured":"Wider C, Ross OA, Nishioka K, Heckman MG, Vilarino-Guell C, Jasinska-Myga B, Erketin-Taner N, Rademakers R, Graff-Radford NR, Mash DC, Papapetropoulos S, Duara R, Uchikado H, Wszolek ZK, Farrer MJ, Dickson DW (2012) An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer\u2019s and Lewy body pathology. J Neurol Neurosurg Psychiatry 83:424\u2013429","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR492","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1212\/01.wnl.0000247041.63081.98","volume":"67","author":"MM Williams","year":"2006","unstructured":"Williams MM, Xiong C, Morris JC, Galvin JE (2006) Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology 67:1935\u20131941","journal-title":"Neurology"},{"key":"1821_CR493","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00415-009-0119-8","volume":"256","author":"CH Williams-Gray","year":"2009","unstructured":"Williams-Gray CH, Goris A, Saiki M, Foltynie T, Compston DA, Sawcer SJ, Barker RA (2009) Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson\u2019s disease. J Neurol 256:493\u2013498","journal-title":"J Neurol"},{"key":"1821_CR494","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","volume":"84","author":"CH Williams-Gray","year":"2013","unstructured":"Williams-Gray CH, Mason SL, Evans JR, Foltynie T, Brayne C, Robbins TW, Barker RA (2013) The CamPaIGN study of Parkinson\u2019s disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry 84:1258\u20131264","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR495","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/brain\/awu119","volume":"137","author":"AR Winslow","year":"2014","unstructured":"Winslow AR, Moussaud S, Zhu L, Post KL, Dickson DW, Berezovska O, McLean PJ (2014) Convergence of pathology in dementia with Lewy bodies and Alzheimer\u2019s disease: a role for the novel interaction of alpha-synuclein and presenilin 1 in disease. Brain 137:1958\u20131970","journal-title":"Brain"},{"key":"1821_CR496","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2006.02.016","volume":"246","author":"R Yamamoto","year":"2006","unstructured":"Yamamoto R, Iseki E, Murayama N, Minegishi M, Marui W, Togo T, Katsuse O, Kato M, Iwatsubo T, Kosaka K, Arai H (2006) Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies. J Neurol Sci 246:95\u2013101","journal-title":"J Neurol Sci"},{"key":"1821_CR497","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3233\/JAD-160062","volume":"52","author":"BS Ye","year":"2016","unstructured":"Ye BS, Lee Y, Kwak K, Park YH, Ham JH, Lee JJ, Shin NY, Lee JM, Sohn YH, Lee PH (2016) Posterior ventricular enlargement to differentiate dementia with Lewy bodies from Alzheimer\u2019s disease. J Alzheimers Dis 52:1237\u20131243","journal-title":"J Alzheimers Dis"},{"key":"1821_CR498","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1468-1331.2007.01977.x","volume":"14","author":"SW Yong","year":"2007","unstructured":"Yong SW, Yoon JK, An YS, Lee PH (2007) A comparison of cerebral glucose metabolism in Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies. Eur J Neurol 14:1357\u20131362","journal-title":"Eur J Neurol"},{"key":"1821_CR499","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/WAD.0000000000000007","volume":"28","author":"JH Yoon","year":"2014","unstructured":"Yoon JH, Lee JE, Yong SW, Moon SY, Lee PH (2014) The mild cognitive impairment stage of dementia with Lewy bodies and Parkinson disease: a comparison of cognitive profiles. Alzheimer Dis Assoc Disord 28:151\u2013155","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1821_CR500","doi-asserted-by":"crossref","first-page":"e0120540","DOI":"10.1371\/journal.pone.0120540","volume":"10","author":"M Yoshita","year":"2015","unstructured":"Yoshita M, Arai H, Arai T, Asada T, Fujishiro H, Hanyu H, Iizuka O, Iseki E, Kashihara K, Kosaka K, Maruno H, Mizukami K, Mizuno Y, Mori E, Nakajima K, Nakamura H, Nakano S, Nakashima K, Nishio Y, Orimo S, Samuraki M, Takahashi A, Taki J, Tokuda T, Urakami K, Utsumi K, Wada K, Washimi Y, Yamasaki J, Yamashina S, Yamada M (2015) Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study. PLoS One 10:e0120540","journal-title":"PLoS One"},{"key":"1821_CR501","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1136\/jnnp-2012-304381","volume":"84","author":"H Yoshizawa","year":"2013","unstructured":"Yoshizawa H, Vonsattel JP, Honig LS (2013) Early neuropsychological discriminants for Lewy body disease: an autopsy series. J Neurol Neurosurg Psychiatry 84:1326\u20131330","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR502","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.parkreldis.2012.06.002","volume":"18","author":"RL Yu","year":"2012","unstructured":"Yu RL, Wu RM, Tai CH, Lin CH, Cheng TW, Hua MS (2012) Neuropsychological profile in patients with early stage of Parkinson\u2019s disease in Taiwan. Parkinsonism Relat Disord 18:1067\u20131072","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR503","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.parkreldis.2016.05.022","volume":"29","author":"W Yue","year":"2016","unstructured":"Yue W, Wang XD, Shi Z, Wang Y, Liu S, Zhang Y, Lu H, Su W, Ji Y (2016) The prevalence of dementia with Lewy bodies in a rural area of China. Parkinsonism Relat Disord 29:72\u201377","journal-title":"Parkinsonism Relat Disord"},{"key":"1821_CR504","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/01.wnl.0000306697.48738.b6","volume":"70","author":"J Zaccai","year":"2008","unstructured":"Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG (2008) Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology 70:1042\u20131048","journal-title":"Neurology"},{"key":"1821_CR505","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jamda.2016.03.017","volume":"17","author":"I Zahirovic","year":"2016","unstructured":"Zahirovic I, Wattmo C, Torisson G, Minthon L, Londos E (2016) Prevalence of dementia with Lewy body symptoms: a cross-sectional study in 40 Swedish nursing homes. J Am Med Dir Assoc 17:706\u2013711","journal-title":"J Am Med Dir Assoc"},{"key":"1821_CR506","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/jnnp-2012-304126","volume":"84","author":"M Zarei","year":"2013","unstructured":"Zarei M, Ibarretxe-Bilbao N, Compta Y, Hough M, Junque C, Bargallo N, Tolosa E, Marti MJ (2013) Cortical thinning is associated with disease stages and dementia in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 84:875\u2013881","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1821_CR507","first-page":"293","volume":"9","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Kim YC, Narayanan NS (2015) Disease-modifying therapeutic directions for Lewy-body dementias. Front Neurosci 9:293","journal-title":"Front Neurosci"},{"key":"1821_CR508","first-page":"567386","volume":"2015","author":"B Zhou","year":"2015","unstructured":"Zhou B, Wen M, Yu WF, Zhang CL, Jiao L (2015) The diagnostic and differential diagnosis utility of cerebrospinal fluid alpha -synuclein levels in Parkinson\u2019s disease: a meta-analysis. Parkinsons Dis 2015:567386","journal-title":"Parkinsons Dis"},{"key":"1821_CR509","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.43.5.986","volume":"43","author":"RM Zweig","year":"1993","unstructured":"Zweig RM, Cardillo JE, Cohen M, Giere S, Hedreen JC (1993) The locus ceruleus and dementia in Parkinson\u2019s disease. Neurology 43:986\u2013991","journal-title":"Neurology"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-017-1821-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-017-1821-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-017-1821-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T19:36:41Z","timestamp":1693337801000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-017-1821-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":510,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["1821"],"URL":"https:\/\/doi.org\/10.1007\/s00702-017-1821-9","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,8]]}}}